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INTRODUCTION 
Glucose metabolism in ruminants differs in many re­
spects from that in other mammals. In non-ruminants, 
dietary carbohydrates are digested to glucose and other 
monosaccharides, absorbed into portal blood, thereby pro­
viding a direct source of carbohydrates for metabolism. In 
ruminants, however, most of the dietary carbohydrates are 
fermented to volatile fatty acids in the rumen (21). 
Acetic, propionic, and butyric acids are the major volatile 
fatty acids formed in the rumen, and of these, propionate 
is the only gluconeogenic precursor. Acetate and butyrate 
are exclusively ketogenic. When ruminants consume diets 
based on forages, less than 10% of the glucose utilized is 
absorbed from the digestive tract (4, 105). 
In ruminants, as in other mammals, glucose serves two 
major functions in metabolism. It provides components for 
synthesis of nucleic acids, proteins, and lipids, which 
are used to construct complex macromolecules of cells. 
In addition, glucose is utilized to provide the energy 
required for the synthesis of macromolecules, and it also 
serves as an energy substrate for functioning of the 
central nervous system (8.4) . 
Ruminants are fully capable of maintaining glucose 
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homeostasis during most physiological states; however, 
during periods of high production, such as lactation in the 
dairy cow or pregnancy in the ewe, glucose homeostasis may 
not be maintained. Because the gluconeogenic process must 
provide up to 90% of the glucose utilized by ruminants 
(84, 88), it is evident that any failure in processes 
regulating gluconeogenesis could cause severe physiological 
perturbations. 
Bovine lactation ketosis is thought to be related to 
or caused by a breakdown in processes regulating glucose 
homeostasis, thereby allowing development of hypoglycemia 
and ketonemia. During later stages of lactation, cows are 
seldom ketotic; however, during early lactation when milk 
production is high, cows are particularly susceptible to 
carbohydrate insufficiency and adipose tissue mobilization. 
It seems that high-producing cows have difficulty adjusting 
feed intake to milk output during early lactation and are 
usually, therefore, in negative energy and protein balance 
(69). 
Krebs (77) described how selective breeding for 
increased milk production has produced cows capable of 
producing much more milk than is required for rearing a 
calf. A typical dairy cow now is capable of producing 
3 
7500 kg of milk during a 305 day lactation, when only a 
few hundred kg is sufficient for rearing a calf. Therefore, 
greatly increased milk production presents a challenging 
physiological stress that can disrupt homeostatic mechanisms 
involved in regulation of metabolism. 
In lactation ketosis, carbohydrate insufficiency and 
adipose tissue mobilization probably originate as the 
result of interplay between at least three factors. The 
first factor is the priority accorded to the lactating 
mammary gland for nutrients, particularly glucose. The 
second is that in early lactation, voluntary food intake 
may be limited, causing an insufficiency in energy for 
maintenance and production. The third is that the endo­
crine status of the cow is oriented to promote lipid 
mobilization (7). It seems that these three factors are 
primarily responsible for development of spontaneous 
lactation ketosis. 
The studies reported in this dissertation were under­
taken to determine the efficacy of using dietary 1,3-
butanediol, which causes ketonemia, and injections of 
phlorizin, which causes glucosuria, to induce an experi­
mental ketosis in steers. Subsequently, effects of keto­
nemia and glucosuria on kinetics of glucose metabolism 
and on in vitro hepatic gluconeogenesis and ketogenesis 
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were determined. In addition, effects of fasting on these 
same variables were studied. Finally, some effects of Ca**-
free incubation media and in vitro additions of ketone 
bodies and long-chain fatty acids on in vitro hepatic 
gluconeogenesis were determined. 
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REVIEW OF LITERATURE 
The purpose of this review of literature is to provide 
the reader, in a concise manner, with a good overview of 
the information available regarding: (a) etiology of 
bovine lactation ketosis, (b) metabolic effects of ketosis, 
(c) gluconeogenic precursors in the ruminant, (d) kinetics 
of glucose metabolism, (d) the need for an experimental 
ketosis, (e) metabolic effects of fasting, (f) metabolic 
effects of phlorizin, and Cg) metabolic effects of 1,3-
butanediol. 
Etiology of bovine lactation ketosis 
Bovine lactation ketosis is a metabolic disorder 
that affects cows during the first few weeks of lactation. 
Ketosis is characterized by ketonemia, hypoglycemia, 
depletion of liver glycogen, hypoinsulinemia, hypophagia, 
fatty liver, and decreased milk production. If ketosis 
occurs spontaneously, i.e., is not accompanied by some 
other physiological abnormality, it is termed primary 
ketosis. If ketosis develops as a result of physiological 
perturbations associated with some other disorder, it is 
termed secondary ketosis. Primary ketosis is observed 
most frequently in high-producing cows that are either 
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over-conditioned (fat) or under-nourished. Secondary 
ketosis frequently occurs in cows suffering from simple 
indigestion, milk fever, metritis, mastitis, or displaced 
abomasum. Whether ketosis is primary or secondary, keto-
nemia and hypoglycemia always occurs. 
Lactation ketosis is rarely fatal, because there is 
usually not complete inappetance and ketosis usually 
remits when milk production has decreased substantially. 
But the more advanced ketosis becomes, the more difficult 
it is to reverse, because of hepatic changes probably 
related to fat deposition, which alter normal liver 
function (121). 
Despite extensive research, the mechanisms responsible 
for development of spontaneous ketosis in cows remain 
unknown. It is doubtful that ketosis is caused by ab­
normal fermentation in the rumen. Radloff and Schultz 
(107) reported that concentrations and proportions of 
volatile fatty acids in the rumen of cows during the early 
stages of ketosis were not different from those in normal 
cows. 
The most accepted theory regarding causes of ketosis 
involves development of a carbohydrate insufficiency or 
"glucose shortage" in cows during the period of negative 
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energy balance in early lactation (8, 121). Bergman (21) 
stated that hypoglycemia is probably the major factor in­
volved in the onset and development of early clinical 
aspects of ketosis. In an eloquent review of the 
literature on bovine ketosis, Baird (8) states, "the key 
factor in rendering dairy cows susceptible to spontaneous 
ketosis is the metabolic priority given to the demands of 
milk production at a time when appetite is limited". In 
lactating cows, the mammary gland, rather than other body 
tissues, preferentially receives nutrients from blood as 
a result of the pattern of hormone secretions during the 
periparturient period (8). During lactation, therefore, 
the gluconeogenic capacity of the liver should increase 
to meet the needs of the cow for glucose for maintenance 
and production. 
A proposed mechanism by which carbohydrate insuf­
ficiency or "glucose shortage" could cause ketosis is 
as follows. First, high levels of milk production and 
the secretion of large quantities of lactose results in 
carbohydrate stress, which causes hypoglycemia in the 
cow. The supply of glucose may not meet the demand for 
glucose, perhaps as a result of either inadequate avail­
ability of gluconeogenic precursors or a limited rate of 
gluconeogenesis. Second, hypoglycemia may cause hypo-
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insulinemia, which subsequently would allow greater 
mobilization of fatty acids from adipose tissue for use as 
energy substrates, thereby increasing influx of free fatty 
acids (FFA) into the liver. Third, in the liver, FFA are 
either reesterified into triglyceride for storage and 
incorporation into very low density lipoproteins (VLDL) 
or are oxidized to carbon dioxide and ketone bodies (KB). 
Factors regulating the metabolism of FFA by liver have 
not been determined fully. Fourth, an influx of large 
quantities of FFA into liver causes a high rate of hepatic 
ketogenesis and the concurrent hypoinsulinemia may limit 
oxidation of KB by peripheral tissues, thereby causing 
ketonemia and the ensuing clinical signs of ketosis. 
Fifth, ketonemia usually is accompanied by hypophagia, 
which causes decreased milk yield. 
Kronfeld (79), in a recent review, offers a 
"heuristic" approach to the problem of ketosis in dairy 
cows and states that a major determinant of development 
of spontaneous ketosis is the ratio of glucogenic to lipo-
genic nutrients in the diet. Kronfeld states that an 
excess of glucogenic nutrients relative to lipogenic 
nutrients is the cause of spontaneous ketosis. The antith­
esis of Kronfeld is based on the following: (1) milk 
volume is determined by the availability of glucose for 
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uptake by the mammary gland, thereby creating a demand for 
lipogenic nutrients; (2) because diets fed to ruminants 
usually have a low fat content, body fat is mobilized to 
meet the needs of the mammary gland for synthesis of milk 
fat; (3) the outcome is that the increased plasma FFA 
concentration causes a proportionate increase in hepatic 
uptake of FFA, and hence, increased hepatic ketogenesis. 
Therefore, in attempts to explain the causes of ketosis, 
the lipid shortage theory of Kronfeld is in direct 
opposition to the glucose shortage theories of Baird C8) 
and Schultz (121). 
The role of glucose in regulating mobilization of 
fatty acids from adipose tissue is especially important 
and concentrations of plasma glucose and FFA are correlated 
negatively to each other (110). Plasma FFA concentration 
is a sensitive index of the nutritional status of an 
animal and is correlated negatively to feed intake (108) 
and correlated positively to blood KB concentration (110). 
The liver is a major utilizer of FFA, with about 25% 
of the total FFA mobilized from adipose tissue being taken 
up regardless of FFA concentrations in plasma (23). Thus, 
when more fatty acids are released from adipose tissue, 
more will be taken up by the liver. Liver and rumen 
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epithelium are the principal sites of ketogencsis in the 
ruminant (20). In liver, the principal precursor of KB 
is FFA (86) and in rumen epithelium, the principal pre­
cursor is butyrate (140).. Ketone bodies should not be 
considered as metabolic waste products, because they serve 
as fuel for respiration in animal tissues and play an 
important role in maintaining caloric homeostasis. Only 
during periods of excessive ketogenesis do ketone bodies 
present a physiological hazard to cows. 
Experiments conducted with fasted cows during 
various stages of lactation demonstrate the priority given 
to synthesis of milk in early lactation. Baird (6) showed 
that, from about 14 to 35 days post-partum, cows will 
attempt to maintain milk yield during food deprivation, 
and as a result, will become ketotic. Baird et al. (10) 
showed that, during later stages of lactation, milk 
production decreases rapidly during food deprivation and 
ketosis is avoided. These reports support the observation 
that dairy cows are most susceptible to ketosis between 
10 and 35 days post-partum and that ketosis often is not 
observed beyond 75 days post-partum (120). 
Krebs (76) described two types of bovine ketosis. 
The first type, physiological ketosis, occurs during 
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starvation or when a low carbohydrate diet is consumed 
and can be considered a normal process for supplying tissues 
with a readily utilizable fuel for respiration. The 
second type, pathological ketosis, often is seen in high-
producing cows and is characterized by severe ketonemia and 
occurs when the quantity of ketone bodies formed grossly 
exceeds possible utilization. Development of pathological 
ketosis seems to occur only when demands on the gluconeo­
genic pathway are great. It is apparent that these two 
types of ketosis are different, yet there is no precise 
boundary distinguishing one from the other and they cannot 
be considered totally different entities. 
Brockman [32) aptly discussed the involvement of 
insulin and glucagon in the development of ruminant 
ketosis and reported that the endocrine system, especially 
the pancreas, probably is involved intimately in the 
development of ketosis. Low concentrations of insulin 
in plasma may cause ketosis by triggering release of fatty 
acids from adipose tissue (32) , by promoting maximal rates 
of hepatic ketogenesis (32), and by impairing utilization 
of KB by peripheral tissues (15). Concentrations of 
insulin in plasma are lower during early lactation than at 
any other time of the lactation cycle and this often occurs 
concurrently with ketonemia (62). 
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The relationship between glucagon and bovine ketosis 
is not known fully, however, it has been reported that 
high concentrations of glucagon may be slightly lipolytic 
and ketogenic in sheep (31). But another report (8) 
indicated that, compared with nonruminants, the ketogenic 
effect of glucagon in ruminants is very low. Studies with 
sheep (31) revealed that insulin can negate the ketogenic 
effect of glucagon. 
Based on available information, it seems that 
spontaneous lactation ketosis is caused, at least partly, 
by an inadequate supply of dietary gluconeogenic precursors 
during the early stages of lactation when milk production 
is great and when cows are in negative energy balance. 
Although hormonal imbalances may be associated closely with 
ketosis, they are secondary to the inability of dietary 
gluconeogenic substrates to meet the nutritional and 
energy demands imposed by lactation and may also be 
secondary to the development of ketosis. 
Metabolic effects of ketosis 
Bovine lactation ketosis is characterized by several 
changes in blood, such as hypoglycemia (6, 20, 78}, 
hyperketonemia (6, 13, 60), hypoinsulinemia (32, 62, 123) , 
and increased FFA (6). Ketosis also involves changes in 
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concentrations of metabolites in liver, such as decreased 
glycogen (13, 60), increased triglyceride (20, 60), and 
increased ketone bodies (13, 60). Baird et al. (10) and 
Baird and Heitzman (9) reported that concentrations of 
intermediates associated with the tricarboxylic acid cycle 
and the Embden-Meyerhof pathway were less in liver of 
ketotic cows than in liver of normal cows. 
It is possible that, during ketosis, hypoglycemia 
is the primary deviation from the normal physiological 
state and that all other changes in blood and liver 
metabolite concentrations are secondary to hypoglycemia. 
This possibility was discussed previously in the section 
dealing with "Etiology of Bovine Lactation Ketosis". 
In ruminants, gluconeogenesis is essential for 
maintaining glucose homeostasis both during periods of 
feeding and food deprivation (88). In nonruminants, how­
ever, gluconeogenesis is of value in maintaining glucose 
homeostasis only during periods of food deprivation 
(16), and the mechanisms that regulate gluconeogenesis 
in non-ruminants have been well elucidated (50, 104, 124). 
The patterns of adaptation of key gluconeogenic enzymes in 
ruminant liver, however, are different from those in non­
ruminants, indicating that the mechanisms that control 
gluconeogenesis in ruminants are unique to the species (16). 
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Flux o£ metabolites through the gluconeogenic pathway 
is mediated by certain key enzymes, namely pyruvate car­
boxylase (PC), phosphoenolpyruvate carboxykinase (PEPCK), 
£ructose-l,6-diphosphatase (FDPase), glucose-6-phosphatase, 
and propionyl-CoA carboxylase. Propionyl-CoA carboxylase, 
PEPCK, and PC are likely to be of importance in hepatic 
metabolism in ruminants in two ways. First, their 
activities may determine the overall rate of hepatic 
gluconeogenesis (21). Second, the relative activities of 
these three enzymes may be of significance in determining 
steady-state concentrations of intermediates of the tri­
carboxylic acid cycle (76). 
Mills (101) reported that, in lactating cows with 
experimental ketosis, gluconeogenic capacity of liver was 
much less than when cows were not lactating or when cows 
were lactating and normal. Mills' findings, however, 
have not been substantiated by other reports. The 
effects of bovine ketosis on activities of the key gluco­
neogenic enzymes are not known fully, however, it seems 
that the gluconeogenic capacity of liver is not altered 
during ketosis. No distinct differences in the activities 
of PC, PEPCK, or FDPase were noted between normal and 
ketotic cows (13). But Ballard et al. (16) reported that 
activity of PC was greater in liver of ketotic cows than in 
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liver of normal cows. Baird and Heitzman (9] and Ballard 
et al. (16) found that activity of PEPCK in liver was not 
affected by ketosis and Hibbitt and Baird (60) reported 
that the activity of FDPase in liver of spontaneously 
ketotic cows was not different from that in normal lactat-
ing cows. Activity of hepatic glucose-6-phosphatase was 
not affected by ketosis (56). Although it is not a 
gluconeogenic enzyme, pyruvate kinase controls the 
glycolytic pathway at the point between phosphoenolpyruvate 
and pyruvate and variations in its activity probably play 
a key role in the regulation of gluconeogenesis. Activity 
of pyruvate kinase was only 60% of normal in liver of 
ketotic cows (56), suggesting that glucose was being 
spared from oxidation. 
Propionate derived from rumen fermentation is con­
sidered to be the major gluconeogenic substrate in fed 
ruminants. Activity of propionyl-CoA carboxylase, which 
regulates the conversion of propionate to tricar­
boxylic acid cycle intermediates, was not different from 
normal when cows were ketotic (13). Mathias and Elliot 
(92) reported that conversion of propionate to tri­
carboxylic acid cycle intermediates in liver homeogenates 
from cows was not affected by ketosis. 
Based on available information regarding activities 
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of enzymes involved with gluconeogenesis, it seems that 
the gluconeogenic capacity of liver is not impaired during 
ketosis. In addition, in vivo experiments indicated that 
glucose irreversible loss was not affected during the 
early stages of spontaneous ketosis (80, 81, 83). There­
fore, it seems that the "glucose shortage" that is im­
plicated in the development of ketosis can be attributed 
to either outflow of glucose exceeding inflow, or to a 
limitation in the availability of gluconeogenic substrates, 
rather than to a limitation in the capacity of liver to 
synthesize glucose. Atwal and Sauer (5) reported that 
precursor availability was the major factor limiting 
hepatic gluconeogenesis in ruminant liver and that the 
availability of glucogenic precursors was determined by 
feed intake and by rates of mobilization of amino acids 
from muscle proteins and of glycerol from adipose tissue. 
The hypophagia that typically accompanies ketosis (120) 
undoubtedly limits availability of glucogenic precursors 
for hepatic gluconeogenesis. 
Gluconeogenic precursors in the ruminant 
Because most of the glucose in diets of ruminants is 
fermented to volatile fatty acids in the rumen and because 
little glucose is absorbed from the intestinal tract, it 
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is apparent that gluconeogenesis is of vital importance 
in maintaining glucose homeostasis. Rates of hepatic 
glucose production in pregnant and non-pregnant sheep 
were, on the average, 85% of the total glucose turnover 
(21), thereby indicating the importance of the liver in 
supplying glucose to the ruminant. 
The four groups of metabolites that serve as sig­
nificant glucogenic substrates in ruminants are: (1) 
propionate, (2) glycerol, (3) amino acids, and (4) lactate 
and pyruvate (51, 74). The relative importance of each 
group still is not known. . Obviously, type of diet con­
sumed, feeding regime, and physiological status of the 
animal would greatly influence relative contributions 
of each compound to gluconeogenesis. 
Propionate is the major gluconeogenic volatile fatty 
acid produced by rumen fermentation (24, 85, 118). The 
conversion of propionate to glucose occurs almost entirely 
in liver (21) and about 90% of the propionate in portal 
blood is removed in every circulation through the liver 
(26, 39). Estimates of the amount of absorbed propionate 
converted to glucose are variable and range from 19 to 
60% in mature sheep (21, 24, 67, 85, 129, 138). Estimates 
of the amount of glucose derived from propionate are 
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variable and range from 27 to 55% (24, 68, 87). On a 
quantitative basis, propionate is probably the most im­
portant glucogenic precursor in the fed ruminant. 
Glycerol is a moiety of triglycerides and, therefore, 
most glycerol in the body exists in combination with 
long-chain fatty acids. Under normal conditions, blood 
contains only small amounts of free glycerol. In fed 
animals, gluconeogenesis from glycerol is small and proba­
bly accounts for less than 5% of the total glucose pro­
duced (25). In the undernourished animal or in heavily 
lactating dairy cows, large amounts of glycerol are 
released from adipose tissue. Under such conditions, 
glycerol can be a quantitatively important glucose pre­
cursor (21). In experiments with fasted and ketotic sheep, 
glycerol accounted for nearly 30% of the glucose production 
(25). 
The contribution of amino acids to gluconeogenesis 
is variable and is influenced by the nutritional and 
physiological status of the animal (21). Amino acids 
derived from muscle protein are important substrates for 
gluconeogenesis during fasting (37). Almost all amino 
acids are glucogenic, with lysine, leucine, and taurine 
being exceptions (75). Any stored amino acids are almost 
exclusively in muscle and these, along with dietary amino 
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acids, are utilized by the liver and kidneys as glucose 
precursors (21). 
From studies with sheep. Ford and Reilly (53) and 
Reilly and Ford (111) estimated that incorporation of 
amino acids into glucose accounted for 13 to 30% of 
glucose turnover. Hunter and Millson (63) reported that 
12% of milk lactose was derived from amino acids in lac-
tating cows. Black et al. (28) and Egan and Black (49), 
using lactating cows and goats, estimated that 30 to 50% 
of glucose turnover may arise from amino acids, of which 
alanine and glutamate each represent 6 to 8% of glucose 
turnover. Wolff and Bergman (139) reported that sheep 
derived at least 11% of their total glucose from the 
composite of alanine, glutamine, glutamate, glycine, and 
serine. As a maximum based on net hepatic amino acid 
uptake, 30% of the glucose could have been derived from 
the total of all glucogenic amino acids. 
Pyruvate is the end-product of glycolysis and if 
cells of actively working muscle become anaerobic, pyruvate 
is reduced to lactate. Both pyruvate and lactate are 
gluconeogenic precursors. When lactate is produced in 
muscle, it is carried by blood to more aerobic organs, such 
as heart, kidneys, or liver for further metabolism. In 
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liver and kidney, lactate either may be oxidized or 
converted to fatty acids or glucose. 
If lactate is converted to glucose, the hexose then 
is released into the blood and may return to muscle for 
synthesis of glycogen or oxidation (84). This cyclic 
process is referred to as the Cori cycle (40) and is of 
significance only when the supply of glucose precursors, 
other than lactate from glucose, is limited. In fed 
ruminants, where the supply of glucose precursors is 
large with respect to the amount actually required, 
the passage of glucose carbon through lactate and back to 
glucose occurs mainly due to a dilution of lactate in 
gluconeogenic precursor pools (84). 
It is important to note that operation of the Cori 
cycle will not result in a net synthesis of glucose, 
because lactate itself is derived from glucose. Lactate 
originating from microbial fermentation in the rumen, 
however, can result in a net synthesis of glucose, but 
ruminai lactate is of quantitative significance only 
when cattle are fed high-concentrate diets. Studies using 
fed sheep (2, 23) indicated that lactate accounted for a 
maximum of 4 to 10% of the glucose turnover. In 
experiments with starved sheep (2), 15% of the glucose 
turnover originated from lactate. 
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Kinetics of glucose metabolism 
Numerous investigations using radioisotope dilution 
techniques have been made of various parameters of 
kinetics of glucose metabolism in ruminants. The most 
frequently reported variables dealing with the kinetics 
of glucose metabolism are irreversible loss (also known 
as entry rate), total entry rate, recycling, pool size, 
and glucose space (137). 
Glucose irreversible loss is the rate at which 
glucose carbon leaves the sampled compartment never to 
return (137). If an animal is in steady state in regard 
to glucose metabolism, then the rate at which glucose 
enters the sampled compartment equals the rate at which 
glucose leaves the sampled compartment, therefore, 
irreversible loss is an estimate of the net rate at 
which new glucose enters the glucose pool. Because, as 
discussed previously in "INTRODUCTION", the ruminant 
must synthesize up to 90% of the glucose utilized, 
irreversible loss also can be regarded as an estimate 
of the net incorporation of glucogenic substrates into 
glucose. Irreversible loss has been determined by using 
single injections of [U-^ '^ C]glucose (3, 83, 84) or by 
using primed-continuous infusions of [U-^ ''C]glucose 
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(3, 19, 82). Young et al. (143), after measuring 
kinetics of glucose metabolism in calves under standard­
ized conditions, reported that values obtained for glucose 
irreversible loss were similar when determined either by 
single injections or by primed-continuous infusions of 
tracer. 
Glucose total entry rate is the rate of entry of 
all glucose carbon into the sampled compartment (137}, 
regardless of whether the glucose is absorbed from the 
intestinal tract, is synthesized from exogenous or endog­
enous precursors, is released by hydrolysis of glycogen, 
or is recycled from another compartment. 
Glucose recycling is the rate of return of glucose 
carbon that temporarily left the sampled compartment (137) 
and recycling occurs by both physical and chemical means. 
The difference between total entry rate and irreversible 
loss is regarded as the rate of recycling of glucose 
carbon between the sampled and other peripheral com­
partments. 
Glucose pool size is the quantity of glucose carbon 
present in the sampled compartment (137). Pool size can 
be regarded as the quantity of body glucose with which 
injected isotopically-labeled glucose mixes. 
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Glucose space is the volume of body water in which 
the glucose pool is distributed (137). Glucose space is 
expressed as a percent of body weight. 
The single-injection technique for measuring the 
kinetics of glucose metabolism allows for determination of 
each of the variables mentioned previously, however the 
primed-continuous infusion technique only allows for 
determination of irreversible loss. But because 
irreversible loss is considered to be the most important 
variable dealing with kinetics of glucose metabolism, 
use of the primed-continuous infusion technique is 
warranted. Because a plateau is determined for blood 
glucose specific radioactivity during primed-continuous 
infusions, estimates can be made to determine whether 
the animal is in steady-state in regard to glucose 
metabolism. However, steady-state conditions cannot be 
verified when the single-injection technique is used be­
cause, when using this technique, blood glucose specific 
radioactivity continually changes following injection of 
tracer. 
Few studies have dealt with changes in the kinetics 
of glucose metabolism caused by lactation ketosis, 
probably because of the high costs associated with such 
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experiments and because of the lack of a predictable 
supply of clinically ketotic cows. Reports by Kronfeld 
et al. (81, 83) and Kronfeld and Raggi (80) indicated 
that glucose irreversible loss and glucose pool size 
were not different from normal during the early stages 
of spontaneous ketosis. Glucose space, however, was 
greater in ketotic cows than in normal cows (78, 83), 
which could explain how hypoglycemia could occur when 
glucose irreversible loss and pool size remained normal. 
Although values for glucose irreversible loss were not 
affected during the early stages of spontaneous ketosis, 
values were decreased during advanced stages of ketosis 
when cows were hypophagic (6, 78). 
Effects of fasting on kinetics of glucose metabolism 
are well-documented, as evidenced by studies which verify 
that glucose irreversible loss is decreased during 
fasting in sheep (128), steers (143),, and cows (78, 80, 
81). It seems, therefore, that during food deprivation, 
the availability of endogenous glucogenic precursors is 
not sufficient to maintain normal rates of gluconeogensis. 
The need for gi experimental ketosis 
A major problem in the study of bovine lactation 
ketosis is the lack of a consistent and predictable 
supply of ketotic cows for use in controlled experiments. 
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Most studies of ketosis have involved analyses of blood 
collected from ketotic cows on dairy farms. But the 
analysis of blood provides information only about 
secondary changes arising from the primary changes in 
individual organs and tissues of ketotic cows. For 
researchers to conduct experiments using body tissues, 
clinically ketotic cows must be available for use at 
laboratories suitably equipped for the surgical removal 
of tissue samples and subsequent study of metabolic 
capacities of the tissues. In addition, experiments 
that involve use of radioactive tracers in ketotic cows 
preclude on-farm experiments, thereby requiring that 
tracer experiments be conducted in suitable research 
facilities. For these reasons, it would be very 
beneficial if a suitable ketosis model could be developed, 
that would eliminate several problems involved in conduct­
ing metabolic experiments with ketotic cows located on 
dairy farms. 
To provide a dependable supply of ketotic cows for 
use in controlled experiments, attempts have been made 
to induce experimental ketosis. Indeed, some forms of 
ketosis in cows have been produced by reducing feed 
intake (12, 33, 52) or by using a combination of reduced 
feed intake and injections of thyroxine (70, 71). 
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Ketosis, accompanied by the clinical symptoms of 
acetonemia, was induced in cows by a combination of high-
protein feeding and injections of L-thyroxine (58, 59). 
Burtis et al. (34) used a combination of starvation, 
hormone, and phlorizin treatments to cause ketosis in 
ewes. 
Both use of fasting, either alone or in combination 
with hormone treatments, and use of lactating cows to 
provide ketotic animals for use in ketosis research create 
problems. When lactating cows are fasted or feed-
restricted, milk production usually declines immediately, 
thereby decreasing or eliminating the causative stress. 
Furthermore, it seems that ketosis induced by starvation 
is not entirely typical of spontaneous ketosis. Kronfeld 
(78) reported that plasma acetate and liver ketone body 
concentrations, mammary acetoacetate release, glucose 
space, and glucose transport rates were greater during 
spontaneous ketosis than during starvation ketosis. 
In addition, it generally is thou^ t that ketonemia causes 
hypophagia during spontaneous ketosis. But an obvious 
contradiction occurs when ketosis is induced by fasting, 
because, in this situation, reduced feed intake preceeds 
ketonemia. 
Use of lactating cows to study ketosis is often 
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impractical, because of the high expenses incurred. 
High-producing dairy cows and the milk they produce are 
valuable and when kinetics of metabolites are studied, 
use of radioactive tracers necessitates disposal of both 
the cow and the milk. Therefore, it would be 
advantageous if a suitable ketosis model, other than the 
feed-restricted cow, was available for use in ketosis 
research. 
Metabolic effects of fasting 
In fasting ruminants, as in other fasted animals, 
the major source of fuel for cellular metabolism is the 
triglycerides of adipose tissue. Through the action of 
lipolytic enzymes and fatty acid-mobilizing hormones, 
fatty acids are hydrolyzed from triglyceride molecules 
and the FFA are transported via blood as a complex with 
plasma albumin to the liver and to other tissues for 
use as energy substrates. Studies indicate that negative 
energy balances imposed on dairy cows by fasting cause 
increased concentrations of FFA in plasma (10, 12, 17, 
112). Negative energy balances imposed by fasting not 
only cause increases in plasma FFA but also cause 
increases in concentrations of blood ketone bodies (10, 
12, 17, 112)., liver ketone bodies (12), liver 
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triglycerides (109), and hepatic outputs of ketone bodies 
(12). Baird et al. (10) reported that fasting caused 
marked reductions in blood glucose concentrations in 
lactating cows, however, in a later study with non-
lactating cows (12), fasting did not cause marked re­
ductions in blood glucose concentrations. 
When lactating cows were fasted for only 24 hours, 
extensive changes in blood metabolite concentrations were 
noted even though there still was a considerable quantity 
of utilizable food remaining in the rumen (10). It 
seems, therefore, that metabolic consequences to fasting 
are rapid, with the purpose of providing body tissues 
with an energy substrate. Robertson et al. (112) and 
Baird et al. (10) reported that mature cows in the 
early stages of lactation developed severe ketonemia 
when fasted for 4 to 6 days. When cows were fasted in 
later stages of lactation, however, susceptibility to 
food-deprivation ketosis was not as great. When non-
lactating cows were fasted for 6 days (12), ketonemia 
occurred, but severity of the ketonemia was no greater 
than that normally seen in healthy, fed cows during 
early lactation. 
It is known that fasting increases hepatic gluconeo­
genic capacity in non-ruminants (119); however, the 
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effects of fasting on hepatic gluconeogenesis are not 
fully known for ruminants. Because gluconeogenesis is 
a continual process in ruminants [88), it is possible 
that fasting does not induce an increase in the process. 
Lindsay (87) indicated there was a decrease in the rate 
of gluconeogenesis when cows were fasted. Baird and 
Young (14) reported that during fasting of lactating 
cows, the activity of propionyl-CoA carboxylase decreased, 
but no effects on activities of PC or PEPCK were noted. 
In other reports, however, fasting caused a decrease 
in PEPCK activity (10, 36). Baird et al. (10) found that 
when lactating cows were fasted, activity of pyruvate 
kinase decreased and activity of glucose-6-phosphatase was 
not affected. 
Changes in blood and liver metabolite concentrations 
caused by fasting are similar to those observed in cows 
having ketosis, which suggests that the two conditions 
are similar. It is likely that the hypophagia that 
usually accompanies ketosis is largely responsible for 
physiological similarities of ketosis and fasting. If 
ketotic cows did not become hypophagic, changes in blood 
and liver metabolite concentrations probably would not 
be as great. Caution must be exercised, therefore, when 
evaluating effects of ketosis on intermediary 
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metabolism, because effects of ketonemia-hypoglycemia and 
hypophagia usually are confounded. 
Metabolic effects of phlorizin 
In mammalian kidney, filtered glucose is almost 
completely reabsorbed in the proximal convoluted tubule 
by an active mechanism with a maximum transport rate 
(27). Von Mering (135,. 136) was the first to report that 
phlorizin (phloretin-2-B-glucoside) caused excretion of 
large amounts of glucose in the urine. The glucosuria 
induced by phlorizin (P) results from an inhibition of 
renal tubular reabsorption of filtered glucose (61, 66, 
93, 106). The interaction of P with proximal tubule 
glucose transport involves both competitive and non­
competitive inhibition (30). Phlorizin also has been 
shown to inhibit glucose transport across intestinal 
brush border in vitro (1). 
It seems that P acts by competing with glucose for 
the membrane receptor site that normally binds glucose, 
thereby preventing the first step in the series of 
reactions that leads to transport of glucose across 
cell membranes in the renal tubule (46). But P itself 
is not translocated across the brush border membrane by 
the glucose transporter (126, 130). Diedrich (46) did 
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not determine whether the glucose moiety of P was solely 
responsible for the inhibitory effects on glucose trans­
port. It seems that some feature of the aglucone moiety 
of P facilitates interaction of the glucosidic portion of 
the molecule with the glucose receptor and, as a result, 
stability of the complex is much greater than that 
formed with the free glucose molecule. 
The ability of P to depress the transfer maximum 
for glucose suggests that P has a much greater affinity 
for the transport receptor site (46). The affinity of 
P for the glucose transport site in both intestine (1) 
and kidney (38) has been estimated to be at least 1000 
times greater than that shown by glucose. 
Although P blocks entry of monosaccharides into 
cells, it does not affect energy yielding processes of 
cells (46). For example, P inhibits penetration of 
hexoses through cell membranes of tissues in which trans­
port of glucose is not energy dependent (18, 43, 102). 
Newey et al. (103) reported that P inhibits intestinal 
transport of glucose at concentrations that do not 
affect the intracellular metabolism of the hexose. 
Other reports, however, suggest that P may cause 
physiological perturbations other than glucosuria. 
Shapiro (125) reported that P decreased glycolysis and 
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the aerobic metabolism of pyruvate and citrate in kidney 
mince. Lotspeich and Keller (89) observed that not only 
oxidation of citrate but also oxidation of all tri­
carboxylic acid cycle intermediates and of 6-hydroxy-
butyrate and glutamate were depressed in kidney upon 
addition of P. Horsburgh et al. (61) stated that 
metabolism of glucose by kidney, expressed as the rate 
of carbon dioxide production, was variably altered by 
P. Eboue-Bonis and Clauser (48) reported that P depressed 
biosynthesis of glycogen in isolated rat diaphragm. 
Other reports indicated that P depressed phosphorylation 
reactions in mammalian tissues (42, 9Q, 113). Whether 
P affects activities of these metabolic pathways in vivo 
is not known. 
Several reports indicate that activities of some 
enzymes are sensitive to P. For example, hexokinase 
(42), phosphorylase (41), and phosphatase (89, 93) are 
inhibited by P in vitro. Phlorizin also inhibited 
activity of glucose-6-phosphate dehydrogenase, 6-
phosphogluconate dehydrogenase, and alkaline phosphatase 
in kidney in vivo, however, activities of these 
enzymes, when from a purified, commercial source, were 
not influenced by P in vitro (144). 
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Most early work with P involved experimentation with 
dogs, however, P has been used more recently with 
ruminants (34, 65, 142). The effects of P in ruminants 
are similar to those observed in nonruminants. Phlorizin 
induces glucosuria in goats (122), sheep (55), and cattle 
(127, 142). Nonpregnant ewes treated with P developed 
ketonemia and hypoglycemia (34, 65) typical of ovine 
pregnancy toxemia; however, despite P-induced changes in 
blood metabolites, clinical signs of ketosis did not 
develop. Other reports indicated that P caused hypo­
glycemia when given to fasted sheep (34, 35, 65) and 
fasted goats (55). Young et al. (142) were the first to 
report results of dose response studies with P in the 
bovine and they found that glucosuria in steers was 
maximal when the P dose was 2 g per day subcutaneously. 
There are only a few studies involving effects of 
P on in vivo kinetics of glucose metabolism. Young 
et al. (142) reported that treatment of steers with P 
caused glucose irreversible loss to increase but did 
not affect pool size or total entry rate of glucose. 
Kolodny et al. (73) reported that P caused a rapid 
increase in hepatic glucose output in normal dogs, but 
not in functionally nephrectomized dogs, indicating 
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that the P-induced increase in hepatic glucose output 
was dependent on loss of glucose from the body via the 
urine. The mechanisms by which P causes increases in 
glucose irreversible loss and hepatic glucose output 
have not been determined, but it was suggested that 
low concentrations of glucose in blood perfusing the 
liver cannot account for the P effect (73). 
Metabolic effects of 1,3-butanediol 
The compound 1,3-butanediol (BD) is a commercially-
available, petroleum-derived glycol that is odorless 
and colorless and has been used as an energy source in 
the diets of rats (94, 95,. 100, 132, 134), pigs (115, 
117), chickens (44, 45, 64), cattle (29, 57, 141), dogs 
(114), and humans (72). The metabolizable energy value 
of BD is approximately 6.5 kcal/g (100), there­
fore, the caloric density of BD is greater than that of 
carbohydrates but less than that of fats. Dymsza and 
Miller (47), Mehlman et al. (94), and Stoewsand et al. 
(131) reported that rats readily consumed BD when it 
was fed at 20% of the diet. Hess and Young (57) and 
Bonner et al. (29) reported that cattle consumed BD 
without toxic effects when it was fed at 4% of the diet. 
35 
however, when cattle were fed BD at 6% of the diet, hyper­
activity and reduced feed efficiency were observed. 
Bonner et al. (29) and Hess and Young (57) reported 
that dietary BD did not affect pH or volatile fatty 
acid concentrations and ratios of rumen contents in 
cattle, suggesting that BD did not affect microbial 
activity in the rumen. Hess and Young (57) reported that 
BD, when mixed with high-concentrate diets, alleviated 
milk fat depression in dairy cows. 
In rats (54, 95, 97, 133), chicks (64), and dogs 
(90), BD is oxidized by the liver to g-hydroxybutyric 
acid, which subsequently is oxidized further in peripheral 
tissues. Mills (101) reported that the liver is at 
least partly responsible for oxidation of BD to 3-
hydroxybutyrate in steers. In addition, studies by 
Hess and Young (57) and Bonner et al. (29) indicated 
that concentrations of acetoacetate and B-hydroxybutyrate 
in blood were greater than control values when BD was 
fed to cattle, suggesting that BD is oxidized to 3-
hydroxybutyrate in ruminants. Therefore, BD seems to 
be an effective ketogenic agent when fed to either 
ruminants or non-ruminants. 
It is not conclusively known whether dietary BD 
affects concentrations of glucose in blood. Bonner et al. 
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(29) and Hess and Young (57) reported that BD did not 
affect blood glucose concentrations in cattle and 
Rosebrough et al. (117) reported similar findings from 
sows. When BD was fed to rats (96, 97) and dogs (114), 
however, blood glucose concentrations were lower than 
control values. Mehlman et al. (96) attributed low 
blood glucose concentrations of BD-fed rats to a blocking 
of gluconeogenesis in kidney at the conversion of 3-
phosphoglycerate to glyceraldehyde-3-phosphate. No other 
reports have indicated that BD affects gluconeogenesis. 
In the reports of Mehlman et al. (96, 97), BD replaced 
a portion of the carbohydrate in diets fed to rats, 
therefore, it is not possible to attribute lower blood 
glucose concentrations in these animals directly to BD. 
Dietary BD possibly could cause a decrease in blood 
glucose concentrations, because BD is a ketogenic com­
pound and ketone bodies stimulate release of insulin 
in sheep (32). It seems, however, that the glucoregula-
tory mechanisms of the body would prevent any long-term 
deviations from physiological concentrations of blood 
glucose when BD is fed. 
Any effects of dietary BD on kinetics of glucose 
metabolism in ruminants are not known. In work with 
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non-ruminants, Romsos and Leveille (114) reported that 
BD did not affect glucose irreversible loss or glucose 
pool size. 
Effects of dietary BD on intermediary metabolism 
in ruminants have not been determined. Romsos et al. 
[116) and Mehlman et al. (96, 97, 98) studied effects 
of dietary BD on enzyme activities in rat liver and 
adipose tissue. Rates of in vitro fatty acid synthesis 
of liver were markedly decreased, however, rates of 
fatty acid synthesis of adipose tissue were not affected 
when BD was fed to rats (116). The marked decrease in 
hepatic fatty acid synthesis in rats fed BD may have 
been caused by an increase in the cytoplasmic NADH/NAD* 
ratio after BD oxidation. An increase in the NADH/NAD* 
ratio would diminish conversion of glucose to fatty 
acids, possibly at the level of glyceraldehyde-3-phosphate 
dehydrogenase and(or) lactate dehydrogenase (116). 
The capacity of the tissues to synthesize fatty 
acids is usually reflected by activities of hepatic and 
adipose tissue malic enzyme. Romsos et al. (116) 
reported that activity of malic enzyme was decreased in 
both liver and adipose tissue only when high levels 
(20% of the diet) of BD were fed to rats. Mehlman et al. 
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(96), however, reported no effects on malic enzyme 
activities in liver and adipose tissue when rats were fed 
diets containing 18% BD. Activities of PC and PEPCK in 
liver were slightly greater in rats fed BD than in rats 
not fed BD (96, 97, 98). Therefore, it seems that in 
addition to causing ketonemia-ketonuria, BD may, in 
some cases, cause other physiological abnormalities when 
fed to animals at moderate to high levels, however, it 
is apparent that BD, in most cases, is readily oxidized 
by body tissues and is not toxic. 
Summary of literature 
Ruminants are dependent on the process of gluco-
neogenesis to maintain a supply of glucose for various 
metabolic needs. During periods of high production, 
such as lactation, the requirement for glucose is great 
and often the supply of glucose does not meet the 
demand. For this reason, high-producing dairy cows, 
during early lactation, experience hypoglycemia which, 
along with hormonal signals, causes the mobilization 
of fatty acids from adipose tissue to meet the energy 
deficit imposed by lactation. The capacity of the liver 
to completely oxidize FFA is sometimes exceeded during 
early lactation, and hepatic ketogenesis increases 
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greatly, thereby causing ketonemia. Bovine lactation 
ketosis, therefore, is characterized primarily by 
hypoglycemia and ketonemia. Advances in understanding 
ketosis have been hindered because of the lack of a 
reliable source of ketotic cows. Development of a valid 
ketosis model would allow researchers to evaluate effects 
of ketonemia on carbohydrate, lipid, and hormonal 
interactions in the bovine. 
Explanation of dissertation format 
This dissertation is presented in the alternate 
format, as outlined in the Iowa State University 
Graduate College Thesis Manual. By using the alternate 
format, the dissertation can be written in sections, each 
independent, and in a form suitable for publication in 
a professional journal, thereby easing the arduous task 
of manuscript preparation, which most graduates encounter 
after writing a dissertation. 
The results of the research that I performed to 
partly fulfill requirements for the Ph.D. degree are 
presented in three separate papers, each with its own 
abstract, introduction, conclusion, and bibliography. 
Although these papers are presented separately, the 
subject matter in them is closely related, allowing for a 
general, integrated discussion at the conclusion. 
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SECTION I. GLUCOSE KINETICS AND PLASMA METABOLITES 
DURING AN EXPERIMENTAL KETOSIS PRODUCED 
IN STEERS BY 1,3-BUTANEDIOL AND 
PHLORIZIN 
54 
ABSTRACT 
Both 1,3-butanediol, which causes ketonemia, and 
phlorizin, which induces glucosuria, were given to steers 
in an attempt to simulate lactation ketosis and to determine 
effects of ketonemia and glucosuria on plasma metabolite 
concentrations and on kinetics of glucose metabolism. Four 
steers received four treatments (control; 1,3-butanediol 
mixed with the control ration; control plus phlorizin given 
by subcutaneous injection; and control plus 1,3-butanediol 
and phlorizin) in a Latin square design. Each treatment 
lasted 14 days. All steers received a 30% grain, 70% 
forage ration in equal portions at 2-h intervals. Plasma 
and urine metabolite concentrations and kinetics of 
glucose metabolism were measured on each of the last 3 
days of each treatment period. Carbon-14 glucose, given 
by single injection, was used to measure glucose kinetics. 
Compared with controls, 1,3-butanediol increased glucose 
pool size. Phlorizin caused glucosuria, decreased plasma 
glucose, increased plasma free fatty acids, increased 
glucose irreversible loss, decreased glucose total entry 
rate, and decreased glucose recycling. Treatment with 
1,3-butanediol plus phlorizin caused glucosuria and 
ketonuria, decreased plasma glucose, increased blood ketone 
55 
bodies, increased plasma free fatty acids, increased glu­
cose irreversible loss, and increased glucose pool size. 
56 
INTRODUCTION 
Lactation ketosis is characterized by increases in 
blood, urine, and milk ketone body concentrations, in­
creases in plasma free fatty acid CFFA) concentrations, and 
decreases in blood glucose concentrations. It generally is 
agreed that a ketotic state is attained when total blood 
ketones (acetoacetate and g-hydroxybutyrate) exceed 10 
mg/dl and blood glucose decreases to 40 mg/dl or less. 
A major problem in studying bovine lactation ketosis 
is lack of a consistent and predictable supply of 
clinically ketotic cows. This problem is compounded by 
high costs of conducting metabolic experiments with lacta-
ting cows. Our primary objective was to develop a model 
of lactation ketosis that would be less expensive than 
high-producing cows for studying ketosis. For a model to 
be valid, the induction protocol would have to: [a] cause 
a glucose excretion that would simulate the lactose re­
moval associated with lactation, (b) reduce plasma glucose 
concentration, (c) produce ketonemia and ketonuria, (d) 
increase plasma FFA concentrations, and (e) maintain feed 
intake until a spontaneous decrease occurs. In an attempt 
to satisfy these criteria, 1,3-butanediol (BD) was fed to 
steers to cause ketonemia and ketonuria, and phlorizin 
57 
was injected to cause glucosuria and, hopefully, a sub­
sequent reduction in plasma glucose concentration. Our 
second objective was to observe effects of glucosuria and 
ketonemia on the kinetics of glucose metabolism in steers. 
Butanediol is an odorless glycol that has been 
used as an energy source in diets of rats (17) , pigs (22) , 
humans (12), and cattle (9, 31). Rats oxidize BD to g-
hydroxybutyric acid (BHBA) in the liver (27). BD is an 
effective ketogenic agent when fed to ruminants (2), and in 
vitro studies (19) indicate that the liver may be partly 
responsible for oxidation of BD to BHBA in steers. Bonner 
et al. (2) reported that rumen pH, volatile fatty acid 
ratios, and blood glucose concentrations were not affected 
in steers fed BD at amounts up to 8% (839 g) of the daily 
ration, but blood ketone bodies were increased, suggesting 
that BD is converted to BHBA in ruminants. The absence of 
an effect of BD on volatile fatty acid ratios and rumen pH 
in cattle suggests that BD is not metabolized by rumen 
microorganisms. 
Von Mering (28) reported that phlorizin (P) caused 
excretion of glucose in urine. The copious glucosuria 
results from both competitive and noncompetitive inhibition 
of renal tubular reabsorption of glucose (3, 11). 
Glucose is essential in ruminants because it is 
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needed by neural tissue, mammary gland, muscle, and the 
fetus and for synthesis of triglycerides. In ruminants, 
gluconeogenesis must provide at least 90% of the necessary 
glucose (32). In lactating cows, glucose required by the 
mammary gland for lactation, coupled with glucose required 
by other body tissues, places a tremendous challenge upon 
the capacity of the gluconeogenic pathway to provide 
sufficient quantities of glucose to maintain glucose 
homeostasis. 
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EXPERIMENTAL PROCEDURES 
One milking Shorthorn and three Holstein steers, with 
initial weights averaging 190 kg, were housed in individual 
pens and received four treatments in a 4 x 4 Latin square 
design. Each treatment period lasted 14 days. Because 
only two automatic feeders were available, two steers com­
pleted the trial before the remaining two began. The con­
trol ration was 30% concentrate and 70% forage, consisting 
of 1470 g ground com plus minerals (5% monosodium phos­
phate and 3% trace-mineral salt) and 3140 g chopped 
alfalfa hay daily. The ration was divided into 12 equal 
portions and fed at 2-h intervals. Water was available 
at all times. Steers gained 300 to 500 g/day. Previous 
work indicated that steers fed according to this regime are 
in metabolic steady state because no diurnal changes in 
kinetics of glucose metabolism occurred (1). 
The control ration (C) was given alone, with BD^ , with 
P^ , and with BD plus P (Table 1). BD was mixed with the 
grain portion of the ration. BD dosage was determined 
during the first 7 days of the 14-day treatment periods. 
B^utanediol was a gift from the Celanese Chemical Co., 
New York, NY. 
P^hlorizin was purchased from Sigma Chemical Co., St. 
Louis, MO. 
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Table 1. Treatments used in the 4x4 Latin square 
Treatment Treatment 
abbreviation composition 
C Control ration 
BD Control ration + 1,3-butanediol 
P Control ration + phlorizin 
BDP Control ration + 1,3-butanediol 
+ phlorizin 
At low BD intake (300 g/day), steers readily consumed their 
rations. BD feeding was increased daily until steers 
began refusing small amounts of feed. The amount of BD 
required to induce this mild hypophagia was noted, and 
amounts subsequently fed were reduced by 10% to insure that 
steers consumed all of their ration. Some steers consumed 
more BD than others without becoming hypophagic. Daily BD 
intake ranged from 450 to 850 g/day per steer. P was 
dissolved in propylene glycol (.25 g/ml), and 1 g of P was 
given subcutaneously twice daily for the last 7 days of 
the treatment period. The P dosage was based upon earlier 
results (33). 
Concentrations of plasma glucose®, blood acetoacetate 
(ACAC) (18) , and BHBA (30) were determined for samples 
*Glucostat, Worthington Biochemicals, Freehold, NJ. 
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obtained on the last 3 days of each treatment period. 
Plasma FFA concentrations were determined by a modification 
(unpublished) of the procedure of Ho (10). Urine glucose 
and ketone body excretion rates were determined by collect­
ing urine from steers in metabolism crates, using NaF as 
the urine preservative, over a 12- to 18-h period. A 
representative sample was assayed for glucose and ketone 
body concentrations (18, 30), and hourly excretion rates 
were calculated. Differences between treatment means were 
tested by using orthogonal comparisons (8, p. 237). 
Kinetics of glucose metabolism were measured on the 
last 3 days of each treatment period by giving each steer 
a single injection of [U-^ '*C]glucose each day and observing 
the decline in plasma glucose specific radioactivity (SRA) 
for the next 8 h. Steers were accustomed to experimental 
conditions. Catheters were placed in both jugular veins 
the day before [^ C^jglucose injections began; one 
catheter was used for withdrawals and the other for in­
jections. A 300-iiCi dose of [U-^ '^ C]glucose, checked for 
radiochemical purity (20), in 18 ml of sterile .15 M 
NaCl was injected through a jugular catheter over a 20-sec 
interval, after which, the catheter was flushed with 50 ml 
of sterile .15 M NaCl. Blood samples were withdrawn at 2, 
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4, 6, 10, 15, 20, 25, 30, 40, 50, 60, 75, 90, 105, 120, 
135, 150, 165, 180, 200, 220, 240, 260, 280, 300, 330, 360, 
390, 420, 450, and 480 min postinjection. 
Plasma glucose SRA. was determined (20). The line of 
best fit for the decline of plasma glucose SRA, as a 
fraction of dose, after injection of tracer was calculated 
by using the nonlinear regression procedure (NLIN) developed 
by Goodnight (8, p. 317). An exponential equation with 
three terms was necessary to fit the data. Subsequently, 
glucose irreversible loss, pool size, total entry rate, 
recycling, and glucose space, as defined by White et al. 
(29), were calculated by using coefficients and exponents 
generated by the NLIN procedure. 
For. data presented in (21) , liver samples were taken 
by puncture biopsy from each steer on the day following 
glucose kinetics experiments. One steer died as a result 
of its third biopsy; therefore, only three steers received 
treatment BD. 
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RESULTS AND DISCUSSION 
Metabolite concentrations in plasma 
Treatment means for urinary glucose excretion rates 
and for plasma glucose and FFA concentrations are in Table 
2. When steers received C or BD, they did not excrete 
measurable glucose in urine, but when P or BDP was given, 
much glucose was excreted. Young et al. (33) reported 
similar results. Glucosuria has been reported also in 
steers (25) and goats (23, 24) treated with P. 
Plasma glucose concentrations were greater during 
treatments C and BD than during treatments P and BDP, 
indicating that subcutaneous injections of P effectively 
caused glucosuria and a decrease in plasma glucose concen­
trations. Others have indicated that P caused hypoglycemia 
when given to fasted sheep (4, 5) and goats (7). Schultz 
et al. (23, 24), however, observed no changes in blood 
glucose concentrations when fed goats received P. Our lack 
of an effect of dietary BD on plasma glucose concentrations 
in steers is in agreement with Bonner et al. (2) and Hess 
and Young (9). 
Plasma FFA concentrations seemed to increase over 
controls when steers received BD, but the 2.6-fold increase 
was not statistically significant (Table 2). When steers 
Table 2. Effects of feeding 1,3-butanediol, injecting phlorizin, and a combina­
tion thereof on urinary glucose excretion and plasma glucose and plasma 
free fatty acid concentrations in steers 
Treatment 
1,3- 1,3-Butanediol Standard 
Variable Control Butanediol Phlorizin + Phlorizin error 
Urinary glucose 0^  0^  200^  248^  34 
excretion (g/day) 
Plasma glucose (mg/dl) 93.8* 94.6® 73.7^  69.6^  .5 
Plasma free fatty 30^  79^ '^  103^  121^  6 
acids (yM) 
**^ Means in rows with different superscript letters differ (P<.01). 
C fî. 
* Means in rows with different superscript letters differ (P<.05). 
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were given P or BDP, plasma FFA concentrations increased 
significantly compared with C. Increased plasma FFA 
concentrations in ruminants receiving P have been reported 
(4, 5). A possible explanation for increases in plasma 
FFA induced by P is that urinary glucose excretion causes 
carbohydrate insufficiency, resulting in increased FFA 
mobilization from adipose tissue, thereby providing an 
alternative substrate for oxidation. This mechanism for 
FFA mobilization from adipose tissue probably would be 
mediated by a decrease in plasma insulin or an increase 
in glucagon or growth hormone concentrations, but as 
reported in an accompanying paper (6), concentrations of 
these hormones in plasma were not affected significantly 
by BD, P, or BDP treatments. 
Treatment means for blood BHBA and ACAC concentra­
tions, BHBA to ACAC ratios, and urinary ketone body 
excretion rates are in Table 3. Blood BHBA and ACAC 
concentrations for treatments BD and P were not increased 
significantly from values for C. When steers received 
BDP, however, BHBA and ACAC concentrations increased 
significantly when compared with other treatments. 
Earlier reports indicated that P caused hyperketonemia 
when given to fasted sheep (4, 5, 7). However, Schultz 
Table 3. Effects of feeding 1,3-butanediol, injecting phlorizin, and a combina­
tion thereof on blood ketone body concentrations, blood ketone body 
ratios, and urinary ketone body excretion in steers 
Treatment 
Variable Control 
1,3-
Butanediol Phlorizin 
1,3-Butanediol 
+ Phlorizin 
Standard 
error 
Blood 3-hydroxybutyrate 
(mg/dl) 
2.5® 5.8* 4.1* 15.6^  .9 
Blood acetoacetate 
(mg/dl) 
.1^  .6* .2* 1.5b .1 
Blood 3-hydroxybutyrate: 
acetoacetate ratio 
31* 11*) 21^  13b 1.3 
Urinary ketone body, 
excretion (g/day) 
0* 1.3* .1* 9.5b 1.4 
**^ '^ Means in rows with different superscript letters differ (P<.05). 
S^um of ACAC plus BHBA. 
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et al. (23, 24) observed no changes in blood ketone body 
concentrations when P was given to fed goats. Bonner et 
al. C2) and Hess and Young (9) reported that feeding BD to 
cows and steers significantly increased total blood ketone 
body concentrations 3- to 10-fold. 
The ratio of BHBA to ACAC in blood was significantly 
less when steers received treatment P than when steers 
received C (Table 3). Further reduction in the ratio was 
noted when treatments BD and BDP were given. The effect 
of P on blood ketone body ratios has not been reported 
previously. The reduction in BHBA to ACAC ratios may 
signify a change in the oxidation:reduction potential in 
tissues that metabolize BD. Tate et al. (27) reported 
that rats converted BD to BHBA by alcohol dehydrogenase 
in liver cytosol. 
When steers received treatment C, ketone bodies were 
not detectable in urine (Table 3). When treatments BD 
and P were given, values increased to detectable amounts, 
but the increases were not significant. When steers 
received BDP, ketone body excretion increased significant­
ly over other treatments. Changes in urinary ketone body 
excretion paralleled changes in ketone body concentrations 
in blood, and significant increases occurred only when BDP 
was given. In contrast to data presented from our study. 
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Bonner et al. (2) and Hess and Young (9) reported that 
feeding BD caused marked ketonuria in steers, but they also 
reported greater concentrations of blood ketone bodies than 
reported here, which may explain the discrepancy. 
Kinetics of glucose metabolism 
A typical curve for the decline in plasma glucose SRA, 
as a fraction of dose, versus time after injection of [U-
glucose is in Figure 1. Both residual sums of squares 
generated by the NLIN iterative procedures and systematic 
deviations between observed and predicted points were 
minimized by using an exponential equation containing three 
terms. Reports indicate that curves generated by the 
decline in plasma glucose SRA as a function of time are 
best described by equations having three exponential com­
ponents (15, 26). 
To accurately determine the area subtended by SRA 
decay curves, Kronfeld and Ramberg (15) state that plasma 
glucose SRA should be measured from as soon as possible 
after administration of tracer until the final slope of the 
SRA decay curve is observed. To verify that a 480-min 
observation period after [U-^ '*C]glucose injection was 
sufficient, slopes of SRA decay curve segments between 240 
and 360 min and between 360 and 480 min (see Figure 1) were 
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Figure 1. Plasma glucose specific radioactivity decay curve 
after intravenous injection of [U-^ '^ C] glucose in 
a steer. Data points represent observed values. 
The equation for the line of best fit to the data 
SRA. = .0041Se"'4119St+ QQ234e"-03361t+ 
.0094e--00*90t. 
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compared by using a paired comparison t-test (8, p. 425). 
Results are in Table 4. Comparisons between slopes of 
these curve segments also were made on SRA decay curves 
from each animal within treatment. In no instance were 
slopes of the two SRA decay curve segments significantly 
different. Because the slope of these SRA decay curves did 
not change after 240 min, an observation period of 480 min 
is considered sufficient. 
Treatment means of variables dealing with kinetics of 
glucose metabolism are in Table 5. Glucose irreversible 
loss (IL) is the rate at which glucose carbon leaves the 
sampled compartment (i.e., plasma) never to return. Be­
cause steers were fed 12 times daily, the supply of 
digestible and fermentable substrate was continuous, and 
steers were in steady state in regard to glucose metabo­
lism. Therefore, glucose IL is an approximate measure of 
the net amount of glucogenic substrate utilized. Glucose 
IL was similar for C and BD treatments. Values increased 
significantly when P and BDP were given. No previous data 
are available regarding the effect of BD on glucose IL in 
ruminants. However, Young et al. (33) reported that P 
caused an increase in glucose IL in steers. In our study, 
the average P-induced increase in glucose IL of 215 g/day 
parallels the average P-induced increase in urinary glucose 
Table 4. Slopes of plasma glucose specific radioactivity decay curve segments 
between 240 and 360 min and 360 and 480 min after [U-^ '*C]glucose 
injection 
Treatment means* 
Treatment 
Slope A 
(240-360 min) 
Slope B 
(360-480 min) 
Difference 
(Slope A - Slope B) T Value PR>Tb 
Control -.0062 -.0065 .0003 .26 .80 
1,3-Butanediol -.0058 -.0059 .0001 .03 .98 
Phlorizin -.0072 -.0069 -.0003 -.37 .72 
1,3-Butanediol 
+ Phlorizin 
-.0078 -.0072 -.0006 -1.14 .28 
*Each mean is the average of 9 to 12 values. 
P^robability that mean difference is significantly different from zero. 
Table 5. Effects of feeding 1,3-butanediol, injecting phlorizin, and a combina­
tion thereof on kinetics of glucose metabolism in steers 
Glucose 
kinetic 
variable 
Treatment 
1,3-Butanediol Standard 
Control 1,3-Butanediol Phlorizin + Phlorizin error 
Irreversible loss 
(g/day) 
Total entry rate 
(g/day) 
Recycling 
(g/day) 
Pool size 
(g) 
Glucose space 
(% body wt) 
410* 
4900' 
4489' 
12. r 
6.4' 
a 434 
5448' 
5OI4C 
15.4' 
7.8' 
575' 
2859" 
2284' 
14.2 c,d 
9.6' 
671' 
3633 c,d 
2962 C,d 
14.9' 
10.7' 
22 
263 
256 
.4 
.4 
to 
**^ Means in rows with different superscript letters differ (P<.01). 
*^^ eans in rows with different superscript letters differ (P<.05). 
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excretion of 225 g/day (Table 2]. Because feed intake was 
constant across all treatments, the mechanism by which 
glucose IL increased in response to P may involve an 
increase in utilization of endogenous glucogenic substrates 
or possibly an increase in the efficiency of utilization of 
glucogenic substrates of dietary origin, or a combination 
of the two. In vitro gluconeogenic capacity of liver 
slices prepared from these steers was greater when P and 
BDP treatments were given (21) , which may explain the P-
induced increase in glucose IL. 
Glucose total entry rate (TER) is the rate at which 
glucose carbon enters the sampled compartment. Glucose 
TER for C and BD treatments was not significantly different 
(Table 5). Values decreased during P and BDP treatments, 
but the decrease was only significant for P. No previously 
reported data are available regarding the effect of BD on 
glucose TER. 
Glucose recycling, occurring by both physical and 
chemical means, is the rate of return of glucose carbon 
that temporarily leaves the sampled compartment and is the 
difference between TER and IL. Glucose recycling rates 
were similar for the C and BD treatments (Table 5). Values 
decreased for P and BDP treatments, but the decrease was 
significant only for P. 
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Young et al. (34) reported much smaller values for 
glucose TER and recycling than those reported here. Glu­
cose TER and recycling values are determined largely by 
the first derivative of the SRA decay curve at the time of 
injection. As the value of the first derivative increases, 
values for TER and recycling increase. Our SRA decay 
curves had greater slopes and Y intercepts (i.e., greater 
first derivatives) than those of Young et al., because our 
first blood samples were drawn at 2 min after tracer in­
jection and the first samples of Young et al. (34) were 
taken 5 min after tracer injection. Therefore, the 
magnitude of glucose TER and recycling is largely influ­
enced by the sampling interval immediately after tracer 
inj ection. 
Glucose pool size is the amount of glucose in the 
sampled con^ artment. Glucose pool sizes for treatments C 
and P were similar, however, when steers received BD or 
BDP, glucose pool sizes were larger than those of controls 
(Table 5). Young et al. (33) reported that glucose pool 
size was not affected by P in steers. No previous data are 
available regarding BD effects on glucose pool size in 
ruminants, but data presented herein indicate a modest, yet 
statistically significant, increase in glucose pool size 
when steers were fed BD. It is possible that ketone bodies 
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derived from BD metabolism may have served as oxidative 
fuels, thereby sparing glucose from oxidation. 
Glucose space, or volume of distribution, expressed 
as a percentage of body weight, was less for treatment C 
and BD than for treatments P or BDP (Table 5). Kronfeld 
et al. (16) and Kronfeld (13) reported an increase in 
glucose space when cows became ketotic. In our study, the 
P-induced decrease in plasma glucose concentrations may be 
a result of the increase in glucose space, to the increase 
in urinary excretion of glucose, or to a combination of the 
two. Similar mechanisms regarding reductions in plasma 
glucose concentrations in ketotic cows have been proposed 
by Kronfeld and Raggi (14), who, after experiments with 
fasted and insulin-treated cows, suggested two types of 
hypoglycemia. The first type, fasting hypoglycemia, 
develops when glucose utilization or outflow exceeds glu­
cose formation or inflow; the second type, insulin-induced 
hypoglycemia, develops when glucose space increases as a 
result of increased cell membrane permeability to glucose. 
The concomitant increase in glucose pool size (Table 5) and 
decrease in plasma glucose concentration (Table 2) when BDP 
was given may be a result of the P-induced increase in 
glucose space. 
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GENERAL DISCUSSION 
When steers received both 1,3-butanediol and phlorizin, 
they exhibited changes in blood glucose, ketone body, and 
FFA concentrations similar to changes observed when cows 
are in early stages of ketosis. Phlorizin-induced gluco-
suria seemed to increase the rate of incorporation of 
glucogenic substrates into glucose, which simulates the 
increased glucose requirement imposed by lactation. Effects 
of 1,3-butanediol and phlorizin on plasma metabolites and 
kinetics of glucose metabolism might have been more marked 
if treatment periods had been longer. 
This model shows potential to provide a consistent and 
predictable supply of relatively inexpensive ketotic cattle, 
allowing the study of carbohydrate, lipid, and hormone 
interactions in ketotic states. It should be especially 
valuable for studying interactions of varying glucose 
excretion rates and varying inputs of ketone bodies in 
cattle. One disadvantage, however, is the high cost of 
phlorizin for inducing glucosuria. 
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SECTION II. PLASMA AND LIVER METABOLITES AND 
GLUCOSE KINETICS AS AFFECTED BY 
PROLONGED KETONEMIA-GLUCOSURIA 
AND FASTING IN STEERS 
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ABSTRACT 
Both 1,3-butanediol, which causes ketonemia, and 
phlorizin, which causes glucosuria, were given to four 
steers for 28 days to determine effects of prolonged 
ketonemia and glucosuria on metabolites in blood and liver 
and on kinetics of glucose metabolism. Ketonemia and 
glucosuria in steers simulates the physiological situation 
in ketotic, lactating cows. In addition, effects of fasting 
on blood and liver metabolites and on glucose kinetics were 
determined. Treatments were: control (1476 g corn, 3144 g 
alfalfa hay daily); control with butanediol plus phlorizin; 
and fasting for 9 days. Butanediol was mixed with the 
corn and phlorizin was injected twice daily. Glucose 
kinetics were measured by primed-continuous infusions of 
[U-i*C]glucose. Butanediol plus phlorizin caused gluco­
suria, ketonuria, and ketonemia, but did not affect plasma 
insulin, glucagon or growth hormone. Fasting caused hypo-
insulinemia but did not affect glucagon or growth hormone. 
Butanediol plus phlorizin and fasting caused 18% and 19% 
reductions in plasma glucose and a 2.5- and 6-fold increase 
in plasma FFA. Butanediol plus phlorizin did not affect 
liver triglyceride or glycogen, but did increase liver 
ketone bodies. Fasting did not affect liver triglyceride 
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or ketone bodies, but did decrease liver glycogen by 60%. 
During control, butanediol plus phlorizin treatment, and 
fasting, glucose irreversible loss averaged 371, 541, and 
182 g/day. Effects of ketonemia-glucosuria on blood and 
liver metabolite concentrations were no greater after 28 
days than after 14 days. Steers given butanediol plus 
phlorizin did not show all the signs of lactation ketosis, 
but the treatment offers promise for studying causes and 
interactions of ketosis. 
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INTRODUCTION 
Bovine lactation ketosis is characterized by hypo­
glycemia (23), hyperketonemia (4), and hypoinsulinemia (17). 
There are also changes in liver metabolite concentrations, 
such as decreases in glycogen (4) and increases in tri­
glyceride (6) and ketone bodies (4). The difficulties in 
conducting research with spontaneously ketotic cows have 
hindered advances in understanding ketosis. To partly 
alleviate the problems, workers have attempted to induce 
ketosis in ruminants by starvation (3, 9, 14), starvation 
plus thyroxine treatment (19, 20), and a combination of 
starvation, hormone, and phlorizin treatments (10). 
Ketosis induced by starvation, however, is not typical of 
spontaneous ketosis (23). 
We reported (11, 28, 32) an attempt to create a 
ketosis model by using maintenance-fed steers receiving 
1,3-butanediol (BD), a ketogenic substrate, and phlorizin 
(P), a compound which causes glucosuria. When BD was fed 
for 14 days and P was injected on the last 7 days of BD 
treatment, blood glucose decreased and blood ketone bodies 
and free fatty acids (FFA) increased (28). However, liver 
glycogen decreased and liver triglyceride (TG) increased 
only slightly (32) and plasma insulin, glucagon, and growth 
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hormone changed only slightly (11). These changes in blood 
and liver metabolites in the steers were in the same 
directions as those in cows during the onset of lactation 
ketosis, but were not as marked. 
For the BDP model of ketosis to be valid, we believe 
that greater decreases in liver glycogen and plasma glucose 
and insulin, along with greater increases in plasma FFA 
and liver TG concentrations are needed. Therefore, we 
attempted to cause greater changes in these metabolites by 
increasing the length of BDP treatment to 28 days. 
In addition to extending BDP treatment, steers were 
fasted for 9 days to determine if the nutritional stress 
imposed by BDP treatment was as great as that imposed by 
food deprivation. We also wanted to determine if steers 
could maintain glucose homeostasis during a prolonged 
fast. The trial reported herein, therefore, allowed 
observations during three physiological states: normal, 
ketonemia-glucosuria (experimental ketosis), and 
starvation. 
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EXPERIMENTAL PROCEDURES 
Two Brown Swiss and two Holstein steers, with initial 
weights averaging 226 kg, were housed in individual pens. 
The trial consisted of four periods and during each period 
all steers were receiving the same treatment. The ration 
was 30% concentrate and 70% forage, consisting of 1470 g 
ground com plus minerals (5% monosodium phosphate, 3% 
trace-mineral salt) and 3140 g chopped alfalfa hay each day. 
The ration was divided into 12 equal portions and fed at 
2-h intervals to maintain a steady metabolic state. Water 
was always available. 
Periods 1 and 3 were control periods; period 2 was 
control plus BD^  and P^  (BDP); and period 4 was fasting 
for 9 days (Table 1). In period 2, BD was mixed with the 
grain portion of the ration. During the first three days 
of BD feeding, BD intake was increased from 300 g/day to 
500 g/day and this amount was fed thereafter. Phlorizin 
was dissolved in propylene glycol (.25 g/ml) and 1 g of P 
was injected subcutaneously twice daily during period 2. 
Period 3 was to prevent possible carryover effects of BDP 
into the fasting period. 
B^utanediol was a gift from the Celanese Chemical Co., 
New York, NY. 
P^hlorizin was purchased from Fluka Chemical Corp., 
Hauppauge, NY. 
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Table 1. Experimental design and treatments 
Period o£ Length of 
trial period (days) Treatment 
1 12 control ration [control I) 
2 28 control ration + BD + P (BDP) 
3 16 control ration (control II) 
4 9 fasted 
D^uring a given period, all steers received the same 
treatment. Periods were in chronological order. 
Concentrations of glucose^ , FFA (37), insulin (41), 
glucagon (16), and growth hormone (42) in plasma and g-
hydroxybutyrate (46) and acetoacetate (30) in blood were 
determined at the end of the first control period, at the 
middle (day 14) and end (day 28) of the BDP period, at 
the end of the second control period, and at the end of the 
fasting period (Table 1). On these same days, excretion 
rates of glucose® and ketone bodies (30, 46) in urine also 
were determined. Plasma glucose, FFA, and hormones for 
each steer were determined in nine samples taken during an 
8-h period (6 a.m. to 2 p.m.). Fluctuations in blood 
metabolite concentrations induced by feeding should have 
been minimized by the 2-h feeding intervals. Liver tissue 
G^lucostat, tforthington Biochemicals, Freehold, NJ. 
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was obtained by puncture biopsy (18) in each period of the 
trial on the days following blood and urine sampling. Con­
centrations of glycogen (21), triglyceride (13) , aceto-
acetate (30), and B-hydroxybutyrate (46) in liver were 
determined. 
Glucose irreversible loss (44) and transfer quotients 
for blood glucose to blood CO2 were determined at the end 
of the first control period, at the middle (day 14) and 
end (day 28) of the BDP period, and at the end of the 
fasting period (Table 1) by using [U-^ '*C] glucose in the 
primed-cpntinuous infusion technique (39). Kinetics of 
glucose metabolism and concentrations of metabolites in 
blood and urine were determined concurrently on the same 
days. Steers were accustomed to experimental conditions. 
Catheters were placed in both jugular veins, one catheter 
for withdrawals and the other for infusions. A primer dose 
of 30 uCi [U-i*c]glucose in 20 ml of sterile .15 M NaCl 
was injected, followed by infusion of .5 iiCi of [U-^ C^]-
glucose per ml of . 15 M NaCl per min for 8 h. Blood 
samples were withdrawn immediately before administration 
of tracer and every 30 min during the last 6 h of the 
infusion. Specific radioactivity (SRA) of plasma glucose 
(31) and blood CO2 (35) were determined. 
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Differences between treatment means for all variables 
were tested by using orthogonal comparisons (15, p. 237). 
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RESULTS AND DISCUSSION 
Plasma metabolite concentrations 
Glucose excretion in urine and concentrations of 
glucose, FFA, insulin, glucagon, and growth hormone in 
plasma are in Table 2. In the control and fasting periods, 
steers did not excrete glucose in urine, however, when BDP 
was the treatment, glucosuria was evident. Excretion of 
glucose is not caused by BD (28), therefore, glucosuria 
during BDP treatment can be attributed solely to P. In 
previous reports (28, 47), glucosuria induced in steers by 
P was similar to that reported here. 
Concentrations of glucose in plasma decreased from 
controls by 18% when steers received BDP, however, the 
steers probably were not as hypoglycemic as clinically 
ketotic cows. Bergman (6) reported that plasma glucose 
concentrations were less than 55 mg/dl during ketosis and 
Kronfeld (23) found plasma glucose concentrations as low as 
27 mg/dl in spontaneously ketotic cows. Data presented in 
(28) indicated that BD had no effect on plasma glucose 
concentrations, and that P, when given alone or in com­
bination with BD, caused plasma glucose concentrations to 
decrease. Data in Table 2 indicate that maximal decreases 
and increases in plasma glucose concentrations and urinary 
Table 2. Effects of 1,3-butanediol and phlorizin treatment and fasting on urinary 
glucose excretion and on plasma glucose, free fatty acid, insulin, 
glucagon, and growth hormone concentrations in steers 
Treatment 
Variable Control I 
BDP 
(day 14) 
BDP 
(day 28) Control II Fasted 
Standard 
error 
Urinary glucose 
excretion (g/day) 
0* 269^  255b 0* 0* 35 
Plasma glucose 
(mg/dl) 
77.9* 66.6^  66.9b 80.9* 65.7b .8 
Plasma FFA (mM) .20^  .32^ 4 .42* .I4G 1.03® .03 
Plasma insulin 
(ng/ml) 
.45* .38* .32*b .43* .09b .02 
Plasma glucagon 
(pg/ml) 
115*b 136* iio*b 101^  98^  2.87 
Insulin:glucagon 
molar ratio 
2.05* 1.68* 1.81* 2.53* .55b .07 
Plasma growth 
hormone (ng/ml) 
10.4^ 4 8.3C 11.3^ 4 13. 2^  9.8=4 .56 
a 
* Means in rows with different superscript letters differ (P<.05). 
»^^ >®Means in rows with different superscript letters differ (P<.07). 
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glucose excretion occurred by day 14 of BDP treatment and 
continued treatment with BDP did not cause further signifi­
cant changes. 
During fasting, concentrations of glucose in plasma 
decreased by 19%, when compared with controls, and were not 
different from those when steers were receiving BDP. 
These observations were made on the eighth day of the fast, 
therefore, the steers probably had been postabsorptive for 
3 to 4 days, suggesting that glucose sparing mechanisms 
and utilization of endogenous substrates for gluconeo-
genesis prevented marked hypoglycemia. When nonlactating 
cows were fasted for 6 days (3) and when steers were 
fasted for 7 days (48), plasma glucose concentratons 
decreased by 10 and 24%. 
Concentrations of FFA in plasma (Table 2) averaged 
.17 mM during the control periods. On days 14 and 28 of 
BDP treatment, plasma FFA concentrations were 1.9- and 
2.5-fold greater than the average during the control 
periods. In an earlier report (28), short-term treatment 
with BDP caused plasma FFA to increase by 4-fold in steers. 
When the steers were fasted in this trial, plasma FFA 
concentrations were over 5-fold greater than the average 
during the control periods. DiMarco et al. (12) fasted 
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steers for 9 days and reported increases in plasma FFA 
concentrations similar to those reported here. 
Concentrations of insulin in plasma were somewhat less 
during BDP treatment than during the control periods 
(Table 2), however, the decreases were not significant. 
deBoer et al. (11) reported similar nonsignificant de­
creases when steers received BDP for shorter periods. 
During BDP treatment, the decrease in plasma glucose may 
have caused the small decrease in plasma insulin; however, 
in cows the correlation between plasma glucose and insulin 
concentrations usually is low (36). Ketone bodies 
stimulate insulin secretion (45), however, during BDP 
treatment, when ketonemia occurred (Table 3), plasma 
insulin concentrations were less than during the control 
periods. It is possible that ketonemia in the steers was 
not severe enough to stimulate insulin secretion. 
In ruminants, FFA concentrations increase in response 
to decreased concentrations of insulin or increased con­
centrations of glucagon and growth hormone in plasma (33). 
The marginal increases in plasma FFA during BDP treatments 
(Table 2) may have been mediated by the slight decrease in 
plasma insulin. 
When steers were fasted, plasma insulin concentrations 
(Table 2) were only 25% of the average during BDP 
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treatment, yet plasma glucose during fasting was not 
different from values during BDP treatment, indicating 
that hypoinsulinemia was not mediated by hypoglycemia. 
During fasting, ruminai volatile fatty acid production un-
doubedly was diminished. It is known that insulin 
secretion in ruminants is stimulated by propionate, 
butyrate, and valerate (8), therefore, the fasting-
induced hypoinsulinemia may have been caused by low con­
centrations of volatile fatty acids in blood. Brockman 
(8) reported that plasma insulin decreased when ruminants 
were fasted. Data in Table 2 suggest that, during fast­
ing, hypoinsulinemia may have contributed to the marked 
increases in plasma FFA. 
Concentrations of glucagon in plasma were not 
affected significantly by BDP treatment or fasting (Table 
2), however, concentrations on day 14 of BDP were greater 
than those during periods 3 (control II) and 4; (fasting). 
Short-term BDP treatment in steers did not affect plasma 
glucagon concentrations in an earlier report (11). 
Brockman (8) reported that plasma glucagon concentrations 
decreased when ruminants were fasted. The marked decrease 
in the insulin to glucagon ratio during fasting (Table 2) 
results from a major decrease in insulin, not an increase 
in glucagon. 
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Growth hormone concentrations (Table 2) did not seem 
to be markedly affected by BDP treatment or fasting, 
however, concentrations on day 14 of BDP treatment were 
less than concentrations during period 3 (control II). 
Short-term BDP treatment (11) in our earlier experiment 
and fasting (43) did not affect concentrations of growth 
hormone in plasma of steers. 
Concentrations and ratios of ketone bodies in blood 
and urine of steers are in Table 3. Blood g-hydroxy-
butyrate (BHBA) and acetoacetate (ACAC) concentrations 
increased 7- and 8-fold when BDP was given. Similar 
increases in blood ketone bodies in steers given BDP for 
shorter periods were reported earlier (28). Ketonemia 
and ketonuria during BDP treatment cannot be attributed 
solely to either BD or P, because neither of the con­
ditions is effectively produced unless BD and P are given 
in combination (28). Although the BDP-induced increases 
in blood ketone bodies were marked in these steers, 
ketonemia was not as severe as in lactating, ketotic cows, 
when total blood ketone bodies have been reported to 
reach 30 mg/dl (6) and 45 mg/dl (4). 
During fasting, BHBA and ACAC concentrations were 
approximately 2.5- and 5-fold greater than controls, but 
the increases were not significant. Baird et al. (3) 
Table 3. Effects of 1,3-butanediol and phlorizin treatment and fasting on blood 
ketone body concentrations and urinary ketone body excretion in steers 
Treatment 
Control BDP BDP Control Standard 
Variable I (day 14) (day 28) II Fasted error 
Blood B-hydroxybutyrate 2.8* 20.7^  16.7^  2.4* 6.9* 1,4 
(mg/dl) 
Blood acetoacetate^  .2* 1.3^  1.7^  1.0*^  .2 
(mg/dl) 
Blood g-hydroxybutyrate: 13 16 10 — 7 .9 
acetoacetate ratio^  
Urinary g-hydroxybutyrate 0* 4.4^  3.3^  0* 0* .5 
excretion (g/day) 
Urinary acetoacetate 0^  2.8^  2.7^  0* 0* .4 
excretion (g/day) 
Urinary g-hydroxybutyrate: 1.6 1.2 .1 
acetoacetate ratio 
**^ Means in rows with different superscript letters differ (P<.01). 
N^ot determined during the second control period. 
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reported that hepatic ketogenesis doubled when nonlactat-
ing cows were fasted for 6 days, causing moderate increases 
in blood ketone body concentrations. During fasting, 
concentrations of ketone bodies in blood increase due to 
increases in hepatic ketogenesis resulting from a greater 
influx of FFA into the liver (34). Data in Tables 2 and 
3 indicate that ketone body concentrations in blood in­
creased only slightly during marked increases in plasma 
FFA during fasting. Therefore, it seems that the rate of 
ketogenesis by the liver is not dependent solely on the 
rate of influx of FFA into the liver, suggesting that 
hepatic ketogenic regulatory factors exist. Bergman (6) 
reported that, in sheep, blood ketone bodies increased in 
direct proportion to increases in plasma FFA only when 
FFA were less than 1.5 mM. When plasma FFA exceeded 
1.5 mM, however, blood ketone bodies increased exponen­
tially. It is possible that the 1 mM FFA [Table 2) in 
fasted steers was not great enough to provide the stimulus 
for an exponential-type increase in blood ketone bodies, 
thereby explaining why fasted steers were not ketonemic. 
Ketone body ratios in blood were not affected 
significantly by BDP or fasting, but a trend toward a 
decrease in ratios occurred during fasting (Table 3). 
Ratios of BHBA to ACAC in ketotic cows (1, 6) are much 
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lower than those reported here. Baird et al. (2) re­
ported that ratios of BHBA to ACAC in blood decreased when 
lactating cows were fasted. 
Steers did not excrete ketone bodies in urine in 
control and fasting periods, however, when BDP was given, 
ketonuria was evident (Table 3). The ratios of BHBA to 
ACAC in urine averaged 1.4 during BDP treatment. Because 
BHBA to ACAC ratios were much lower in urine than in 
blood, it seems that either extensive conversion of BHBA 
to ACAC occurred in the kidneys or that preferential 
excretion of ACAC over BHBA by the kidneys occurred. 
Prolonged BDP treatment [i-e., longer than 14 days) did 
not increase the severity of ketonemia or ketonuria. 
In preliminary studies, we found that the severity of 
ketonemia in steers receiving BDP was related to the 
amount of BD fed. If more BD could be fed for a prolonged 
period (e.g., 1000 g/day for 7 days) in combination with 
P injections, more severe ketonemia could be produced. 
But caution must be taken when feeding BD, because if too 
much is fed, steers become anorexic and exhibit signs of 
extreme hyperactivity and nervousness (7). 
Kinetics of glucose metabolism 
Glucose irreversible loss (IL) and blood CO2 transfer 
quotients (TQ) during periods 1, 2, and 4 are in Table 4. 
Table 4. Effects of 1,3-butanediol and phlorizin treatment and fasting on 
kinetics of glucose metabolism in steers 
Treatment 
BDP BDP Standard 
Variable Control I (day 14) (day 28) Fasted error 
Glucose irreversible 371* 481^  600^  182^  41 
loss (g/day) 
Blood CO: transfer 1.5® 3.2^  4.4% 4.7^  ..4 
quotient (%) 
a,b,c,d^ gg^ g in rows with different superscript letters differ (P<.01). 
®*^ '®Means in rows with different superscript letters differ (P<.05), 
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Glucose kinetics were not determined during period 3 be­
cause control values from period 1 already had been 
determined. Compared with controls, glucose IL was 30% 
greater on day 14 and 62% greater on day 28 of BDP treat­
ment and these differences are highly significant. Because 
the steers were fed every 2 h, they were in metabolic 
steady state, which is essential when conducting primed-
continuous infusions to determine the kinetics of glucose 
metabolism. An increase in glucose irreversible loss in 
BDP-treated steers strongly suggests that net incorporation 
of substrates into glucose increased in response to keto-
nemia-glucosuria. In an earlier report (28), it was shown 
that glucosuria during BDP treatment was associated with 
an increase in glucose IL, indicating that a greater 
utilization of glucose caused net synthesis of glucose to 
increase. Previously, glucose IL was shown to increase by 
40 to 65% in steers receiving short-term BDP treatment 
(28) .  
The mechanisms by which BDP mediates increases in 
glucose IL in steers is not known. It seems, however, that 
P-induced glucosuria may be a primary stimulus for in­
creased gluconeogenesis, because BD, given alone, does not 
affect glucose IL (28). Kolodny et al. (22) observed rapid 
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increases in hepatic glucose output when dogs received P, 
and the increases could not be attributed to low glucose 
concentrations in blood perfusing the liver. The authors 
(22) speculated that the P-induced increases in hepatic 
glucose output were mediated by neural, neurohumoral, or 
humoral systems located in extrahepatic tissues. 
On day 14 of BDP treatment, average urinary glucose 
excretion (Table 2) exceeded the average BDP-induced 
increase in glucose IL by 159 g (Table 4). On day 28 of 
BDP treatment, however, urinary glucose excretion was only 
26 g in excess of the increase in glucose XL, suggesting 
that an improvement in glucose homeostasis occurred after 
prolonged BDP treatment. 
As reported in the accompanying paper (27), in vitro 
gluconeogenic capcity of liver slices obtained by biopsy 
from the steers was greater when BDP was given than when 
the control treatment was given. Increases in hepatic 
gluconeogenic capcity may explain how glucose IL increased 
during BDP treatment. An increase in glucose IL strongly 
suggests that the net amount of substrates used for glucose 
synthesis increased. But equal amounts of feed were given 
in the control and BDP periods and BD is not a glucogenic 
precursor and has no known effect on rumen fermentation ~ 
103 
(7). Therefore, the amount of dietary glucogenic pre­
cursors available for gluconeogenesis should have been 
identical during both periods. It is possible that 
utilization of endogenous precursors (i.e., amino acids, 
glycerol) for gluconeogenesis increased when BDP was given 
or that exogenous (dietary) and(or) endogenous precursors 
were selectively used for gluconeogenesis when BDP was 
given, thereby explaining how IL could increase when the 
amount of exogenous glucogenic precursors did not increase. 
Kronfeld et al. (25) reported that glucose IL was similar 
in ketotic and normal lactating cows, suggesting that 
ketonemia per se does not affect glucose IL. 
Glucagon promotes hepatic glucose output by both 
gluconeogenesis and glycogenolysis (8). The increases in 
glucose IL during BDP treatment were not associated with 
increases in concentrations of plasma glucagon. Therefore, 
unless changes in glucagon concentrations in jugular vein 
blood are not representative of changes occurring in portal 
vein blood, it seems that increases in glucose IL were not 
mediated by increased glucagon secretion. 
Glucose IL was reduced by 50% when steers were fasted, 
compared with control values (Table 4), suggesting that 
glucose was effectively conserved. It is likely that 
ketone bodies and FFA served as alternative energy sub-
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strates during fasting. Low glucose IL during fasting 
also suggests that the supply of endogenous gluconeogenic 
precursors was not great enough to maintain normal rates 
of gluconeogenesis during prolonged starvation. Steele and 
Leng (38) fasted pregnant sheep for 4 days and reported 
a 51% decrease in glucose IL. Kronfeld and Raggi (24) 
fasted lactating cows for 3 to 4 days and reported a 50% 
decrease in glucose IL. 
Blood CO2 TQ (Table 4) was higher during BDP and 
fasting than during the control period. Control values are 
too low and may be in error, making comparisons with 
controls questionable. Veenhuizen (unpublished, ISU 
Master's Thesis, Ca. 1983) reported TQ values of 7% in 
steers receiving the same ration as used here. 
Liver metabolite concent rat ions 
Concentrations of triglyceride, glycogen, and ketone 
bodies in liver are in Table 5. Concentrations of TG in 
liver were slightly greater during BDP treatment than 
during the control periods, but the increases were not 
significant. Mills et al. (32) reported similar findings 
in steers treated with BDP for shorter periods. Therefore, 
even prolonged treatment with BDP does not cause 
significant development of fatty liver in steers. Ketotic 
Table 5. Effects of 1,3-butanediol and phlorizin treatment and fasting on liver 
metabolite concentrations in steers 
Treatment 
Liver 
metabolite 
Control 
I 
BDP 
(day 14) 
BDP 
(day 28) 
Control 
II Fasted 
Standard 
error 
Triglyceride (%) .63 1.02 .82 .47 1.38 .15 
Glycogen (%) 3.60* 3.07* 3.30* 3.19* 1.35b .26 
3-hydroxybutyrate 
(nmoles/g tissue) 
398* 2071^  1565^  616* 622* 175 
Acetoacetate 
(nmoles/g tissue) 
197=^  292^ ® 366® 232^ ® 64= 32 
0-hydroxyb;utyrate to 
acetoacetate ratio 
2.0= 7.1=d 4.3= 2.7= 9.8^  1.6 
' Means in rows with different superscript letters differ (P<.01). 
=»^ »®Means in rows with different superscript letters differ (P<.05). 
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cows often have liver TG concentrations of 10% (6). The 
uptake of FFA by ruminant liver has been reported to be 
directly proportional to the rate of mobilization of FFA 
from adipose tissue (6). Because plasma FFA concentrations 
were not elevated markedly during BDP treatment, liver TG 
did not increase markedly either. 
Concentrations of TG in liver increased by about 
two fold when steers were fasted, compared with control 
values, but the increases were not significant (Table 5). 
Because plasma FFA concentrations were increased sig­
nificantly during fasting, it seems that liver TG should 
have increased also. It is possible, however, that the 
alternative pathways of FFA utilization in the liver 
(lipoprotein formation or oxidation) were sufficiently 
active to prevent formation of fatty liver. Reid et al ; 
(34) fasted nonlactating cows for 6 days and found that TG 
content of liver was only 2.7%. 
Glycogen content of liver was only slightly less 
during BDP treatment than during the first control period, 
however, values during the second control period were 
slightly less than those on day 28 of BDP treatment (Table 
5). Previously, liver glycogen in steers was shown to 
not be affected by short-term BDP treatment (32). There­
fore, it seems that even during prolonged BDP treatment. 
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glucosuria did not cause a carbohydrate loss or stress 
in steers great enough to cause serious metabolic con­
sequences, as evidenced by normal glycogen concentrations 
in liver. Baird et al. (4) reported that liver glycogen 
in normal lactating cows was 4-fold greater than in ketotic 
cows, however, they could not attribute the lower glycogen 
levels directly to ketonemia because cows were also 
hypophagic during ketosis. 
When steers were fasted, liver glycogen was 63% less 
than when steers received the control treatment (Table 5), 
obviously indicating that fasting induced carbohydrate 
stress to a much greater extent than did BDP treatment. 
Baird et al. (3) fasted nonlactating cows for 6 days and 
reported a 71% decrease in liver glycogen. 
Concentrations of BHBA in liver (Table 5) were much 
greater during the BDP period than during the control or 
fasting periods and BHBA concentrations in blood and 
liver were highly correlated (r = .99). Butanediol is 
oxidized to BHBA in liver of rats (40) and steers (32), 
therefore, it seems that BHBA concentrations in blood 
depend on the extent to which BD is metabolized by liver. 
Concentrations of ACAC in liver (Table 5) did not increase 
as markedly as did BHBA when BDP was given, but a 
significant increase was noted on day 28 of BDP treatment. 
108 
Concentrations of ACAC in blood and liver were not highly 
correlated (r = ,56). 
Ratios of BHBA to ACAC in liver (Table 5) were 
greater, but not significantly so, when steers received 
BDP than when the control treatment was given, suggesting 
that BD is oxidized preferentially to BHBA rather than to 
ACAC. Blood ketone body concentrations (Table 3) during 
BDP treatment also suggest that BD is oxidized pre­
ferentially to BHBA. Mehlman et al. (29) reported that 
BD was, in some cases, oxidized preferentially to BHBA 
in liver of rats. When steers were fasted, BHBA to ACAC 
ratios increased significantly over controls, suggesting 
that fatty acids mobilized from adipose tissue were 
oxidized preferentially to BHBA. Baird et al. (2), 
however, reported that ratios of BHBA to ACAC in liver 
decreased when lactating cows were fasted. 
Increases in ketone body concentrations in liver 
during BDP treatment are similar to those reported for 
liver of ketotic cows (4). The absence of marked in­
creases in ketone bodies in liver of the fasted steers 
does not agree with reports (3, 5) indicating that liver 
ketone bodies increased greatly when nonlactating cows 
were fasted. Concentrations of FFA in plasma of fasted 
cows (2, 6) are more than two fold greater than those 
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reported for these steers. Therefore, it seems that the 
greater influx of FFA into liver of fasting cows may-
account for the greater production of ketone bodies. 
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GENERAL DISCUSSION 
Prolonged treatment with 1,3-butanediol and phlorizin 
(i.e., greater than 14 days) did not cause further changes 
in concentrations of metabolites in blood and liver, in­
dicating that metabolic adaptations to ketonemia-gluco-
suria occurred rapidly. Ketotic cows exhibit decreases 
in plasma glucose and insulin and liver glycogen and 
increases in blood ketone bodies, plasma FFA, and liver 
triglyceride greater than those occurring in BDP-treated 
steers. These greater changes indicate that the metabolic 
stress imposed by lactation in cows fed ad libitum is 
greater than the stress imposed by BDP treatment in 
maintenance-fed steers. 
Observations with ketotic cows sometimes are 
difficult to interpret because effects of ketonemia and 
lactation on metabolites in blood and liver often are 
confounded with effects of hypophagia, which usually 
accompanies ketosis. When steers received 1,3-butanediol 
and phlorizin, feed intake was not different from that 
during control periods, therefore, changes in blood and 
liver metabolites could be attributed solely to ketonemia-
glucosuria. 
When giving 1,3-butanediol and phlorizin to steers, 
assumptions are made that the only physiological 
I l l  
perturbations are ketonemia, ketonuria, and glucosuria. 
Butanediol does not seem to affect rumen fermentation (7) 
and, as discussed in (28), its successful use as an 
energy source in diets of animals is well-documented. 
Furthermore, BD is oxidized readily to BHBA by steer 
liver slices in vitro (32), indicating that BD is not 
toxic to animal tissues. Phlorizin prevents transport of 
glucose into cells of the proximal tubules in kidney and 
into cells of the intestinal brush border also (26). But 
it seems that phlorizin does not inhibit uptake of glucose 
by peripheral tissues (22). As discussed in the 
accompanying paper (27), however, phlorizin, under certain 
conditions, inhibits activities of some enzymes involved 
in carbohydrate metabolism, which indicates that the 
effects of phlorizin may not be limited to inhibition of 
glucose transport. 
Due to lactation and hypophagia, ketotic cows 
probably experience much greater physiological stress than 
did steers treated with BDP. This greater stress probably 
explains why changes in blood and liver metabolites are 
much more marked in ketotic cows than in steers receiving 
BDP. Probably a more marked physiological stress could 
be imposed on steers if a sub-maintenance ration was fed 
during BDP treatment, but this would only invoke the 
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invalidity associated with feed-restricted kctosis models. 
Even though the BDP regime does not cause a ketosis in 
steers as severe as that seen in lactating cows, it can 
still be of great value in determining the effects of 
ketonemia-glucosuria on intermediary metabolism in the 
bovine. 
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SECTION III. IN VITRO HEPATIC GLUCONEOGENESIS AND 
KETOGENESIS AS AFFECTED BY PROLONGED 
KETONEMIA-GLUCOSURIA AND FASTING IN 
STEERS 
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ABSTRACT 
Both 1,3-butanediol, which causes ketonemia, and 
phlorizin, which causes glucosuria, were given to four 
steers for 28 days to determine effects of prolonged 
ketonemia and glucosuria on hepatic gluconeogenesis and 
ketogenesis in vitro. Effects of prolonged fasting on 
these variables also were determined. In addition, 
effects of Ca**-free incubation media and in vitro 
additions of ketone bodies, fatty acids, defatted bovine 
serum albumin, NAD*, and niacin on hepatic gluconeogenes 
were determined. Treatments were: control [1476 g corn 
3144 g alfalfa hay daily); control with butanediol plus 
phlorizin; and fasting for 9 days. Butanediol was mixed 
with the corn and phlorizin was injected twice daily. 
Liver, obtained by puncture biopsy, was incubated with 
carbon-14 labeled 10 mM propionate, lactate, alanine, 
glycerol, butyrate, and 1 mM palmitate. Glucose pro­
duction [nmoles substrate converted to glucose/(100 mg 
liver X 2 h)] during control, butanediol plus phlorizin, 
and fasting averaged 467, 1441, and 2400 for propionate; 
198, 760, and 2452 for lactate; 59, 151, and 444 for 
alanine; and 411, 1073, and 1155 for glycerol. The 
absence of Ca** in incubation media eclipsed the BDP-
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and fasting-induced increases in hepatic gluconeogenesis. 
Additions of ketone bodies (5 mM), octanoate (1 mM), 
bovine serum albumin (3%), NAD* (.45 mM), and niacin 
(.5 mM) did not markedly affect glucose production from 
propionate or lactate, however, some changes were noted. 
Stearate (1 mM), bound to albumin, greatly inhibited 
gluconeogenesis during control and butanediol plus 
phlorizin, but not during fasting, g-hydroxybutyrate 
production [nmoles/(100 mg liver x 2 h)] during control, 
butanediol plus phlorizin, and fasting averaged 414, 853, 
and 650 for butyrate and 12, 54, and 3 for palmitate. 
Hepatic gluconeogenesis was increased by both ketonemia-
glucosuria and fasting, indicating that gluconeogenic 
capacity of ruminant liver is responsive to the physio­
logical and nutritional status of the animal. 
121 
INTRODUCTION 
Lactation imposes a tremendous metabolic challenge on 
high-producing dairy cows, necessitating the synthesis of 
large quantities of glucose from noncarbohydrate pre­
cursors. Such cows often become ketotic during early 
lactation for reasons which still are not understood 
fully. Effects of ketosis on intermediary metabolism are 
not known completely and the lack of a consistent and 
predictable supply of spontaneously ketotic cows has 
impeded advances in ketosis research. 
Effects of lactation ketosis on hepatic gluco­
neogenic enzyme capacities are not understood fully. 
Baird et al. (3) reported that concentrations of Krebs 
cycle and Embden-Meyerhof pathway intermediates in livers 
of cows were decreased by ketosis. Baird et al. (2) 
measured activities of gluconeogenic enzymes in livers of 
normal, lactating cows and of ketotic, lactating cows and 
reported that, except for fructose diphosphatase, enzyme 
activities were greater in livers from ketotic cows than 
in livers from normal cows, which suggests that hepatic 
gluconeogenic capacity would be increased during ketosis. 
Whether these in vitro observations are indicative of the 
true in vivo condition remains to be proven. 
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Interpretation of data regarding the effects of 
ketosis on metabolite concentrations and enzyme activities 
in tissues of cows is complicated by the uncertain 
differentiation between the true ketotic state (spontaneous 
ketosis) and the hypophagic state that later accompanies 
the disorder. Baird et al. (3) reported that healthy, 
lactating cows subjected to starvation became ketotic and 
exhibited changes in blood and liver metabolite concen­
trations similar to those observed in cows with 
spontaneous ketosis, which led those authors to question 
whether there were any differences in intermediary 
metabolism between cows suffering from starvation ketosis 
and those with spontaneous ketosis. Kronfeld (17), 
however, indicated major distinctions between spontaneous 
and starvation ketosis, which included higher plasma 
acetate and liver ketone body concentrations, greater 
mammary acetoacetate release, and greater glucose space 
and glucose transport rates in the former. 
Earlier (8, 23, 28), and in an accompanying paper 
(22), we have reported attempts to create a ketosis model 
using steers fed 1,3-butanediol (BD) and injected with 
phlorizin (P). Butanediol is a ketogenic substrate and P 
is a compound that causes glucosuria. In (23), BD was fed 
for 14 days and P was injected during the last 7 days of 
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BD feeding. Steers were ketonemic when liver biopsies were 
performed and, compared with controls, in vitro hepatic 
gluconeogenic capacities increased. These observations 
were different from those in cows having an experimental 
ketosis, where in vitro hepatic gluconeogenic capacities 
were impaired (26). 
Because our earlier work showed promise for causing 
a useful experimental ketosis, we wanted to determine 
the effects of extended treatment with BD and P on hepatic 
metabolism. The first objective was to determine the 
effects on in vitro hepatic gluconeogenic and ketogenic 
capacities caused by prolonged ketonemia and glucosuria 
in steers during treatment with BD and P for 28 days. 
Second, we determined effects of prolonged starvation on 
in vitro hepatic metabolism, thereby allowing comparisons 
between three physiological states: normal, ketonemia-
glucosuria (experimental ketosis), and starvation. 
Under some circumstances, long-chain fatty acids 
(LCFA) can increase gluconeogenesis from a variety of 
substrates in liver slices and in perfused rat liver (31). 
When LCFA are added to tissue preparations in a physio­
logical manner, however, they do not stimulate in vitro 
hepatic gluconeogenesis in rats (30). The effects of 
LCFA and ketone bodies on gluconeogenesis in ruminant 
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liver in vitro are not known. Therefore, the third 
objective was to determine effects of LCFA and(or) ketone 
body additions on rates of in vitro hepatic gluconeo-
genesis in liver slices from steers receiving control or 
BDP treatments and from steers that were fasted. 
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MATERIALS AND METHODS 
Experimental design 
Care of the four steers, experimental design, and 
ration composition were described in the accompanying 
paper (22). Briefly, the trial consisted of four periods. 
In periods 1 and 3, the control ration was given; in 
period 2, control plus BD^  and (BDP) was given for 28 
days; and in period 4, steers were fasted for 9 days. 
The control treatment was repeated in period 3 to prevent 
possible carryover effects of BDP into the fasting period. 
Liver biopsy 
Liver biopsies were performed at the end of the first 
control period, at the middle (day 14) and end (day 28) 
of the BDP period, at the end of the second control period, 
and at the end of the fasting period. Tissue was obtained 
by the puncture biopsy technique (13), except for the 
fasting period, when liver was obtained via laparotomy 
just prior to sacrificing the steers. Puncture biopsy is 
advantageous because it allows repeated sampling from the 
B^utanediol was a gift from the Celanese Chemical Co., 
New York, NY. 
P^hlorizin was purchased from Fluka Chemical Corp., 
Hauppauge, NY. 
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same animal, but the disadvantages, especially in smaller 
animals, are difficulty in obtaining enough tissue for 
large-scale incubations and risk of death from excessive 
hemorrhage. Six to 8 g of liver normally were obtained, 
.5 g was rinsed immediately in cold .15 M NaCl and 
submerged in liquid nitrogen. The remaining liver tissue 
was kept in cold buffered (pH 7.4) .15 M NaCl. Frozen 
liver was stored in an airtight container at -80"C until 
assayed for metabolite concentrations. Fresh tissue 
was incubated as soon as possible, normally within 3 h. 
Incubation procedure 
Liver biopsy cores were sliced using a Stadie-Riggs 
tissue slicer. Seventy to 100 mg of slices were incubated 
with substrates (1 yCi of ^ C^-labeled substrate plus 30 
ymoles of non-labeled substrate) in 25 ml Erlenmeyer 
flasks containing 3 ml of pH 7.4 Krebs-Ringer bicarbonate 
(KRB) buffer (9). When LCFA or ketone bodies were added, 
Ca** was omitted from the buffer. Flasks were gassed with 
95% O2 - 5% CO2, hanging wells containing folded filter 
paper were suspended for *^*002 collection and flasks 
were stoppered. Incubations were for 2 h at 37°C in a 
metabolic shaker. Incubations with each substrate usually 
127 
were conducted in triplicate, however, on some occasions, 
tissue was limited and incubations then were only in 
duplicate. 
Incubations were terminated by injecting .5 ml of 
10% HClOi» into the media. To trap ^^ COz, 100 pi of 25% 
NaOH was injected onto the filter paper in the hanging 
well. Acidified media was shaken for 1 h to evolve 
Filter papers were removed and placed in vials. 
Radioactivity was determined by liquid scintillation 
counting. 
Hepatic gluconeogenic capacities and substrate 
oxidation rates were measured by using Na-[2-^ '*C]propio-
nate, Na-L(+)[u-^ *C]lactate, L-[U-.^ '*C]alanine, and L-[U-
glycerol. All substrates were 10 mM. Effects of 
additions of ketone bodies [5 mM) and stearate con­
jugated to bovine serum albumin (1 mM stearate bound to 
defatted BSA, final BSA concentration 3%) on gluconeo­
genic capacities and substrate oxidation rates of liver 
slices using Na-[2-propionate and Na-L(+) [U-^ C^]-
lactate as substrates were determined on day 28 of BDP 
treatment, at the end of the second control period, and 
at the end of the fasting period. Effects of separate 
additions of octanoate (1 mM) and BSA (defatted, final 
128 
BSA concentration 3%) on gluconeogenic capacities and 
substrate oxidation rates of liver slices using Na-[2-^ '*C]-
propionate as substrate were determined also. Effects of 
additions of NAD^  (g-, final concentration .45 mM} and 
niacin (final concentration .5 mM) on gluconeogenic 
capacities and substrate oxidation rates of liver slices 
using Na-[2-^ "^ Clpropionate as substrate were determined 
at the end of the fasting period. 
Hepatic ketogenic capacities and substrate oxidation 
rates were measured by using the two substrates, Na-fl-^ C^] 
butyrate (10 mM) and [1-^ C^jpalmitate-BSA complex (1 mM 
palmitate plus 1 uCi of [l-^ C^] palmitate both bound to 
defatted BSA, final BSA concentration 3%). Ketone body 
production rates were corrected for endogenous liver 
ketone body content by measuring ketone bodies released 
from tissue incubated in media acidified with .5 ml of 
10% HCIO4. 
Analytical procedures and presentation of data 
Following collection, acidified media were 
spiked with 5500 DPM of [6-^ H]glucose. Flask contents 
were transferred to 50 ml tubes and centrifuged. The 
supernatant was neutralized with solutions of 5% and 10% 
KOH. Concentration of g-hydroxybutyrate (BHBA) in 
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neutralized medium was measured (37). Glucose in 
neutralized medium was isolated by using anion-cation ex­
change columns (27) and radioactivity and glucose concen­
tration' in the column eluate were both quantified. 
Recoveries of "^*0 radioactivity and glucose were corrected 
for recovery of the [6-'H]glucose. Background radio­
activity was measured in triplicate for each substrate by 
processing media that contained no tissue. Metabolic 
rates were based upon wet weights of tissue incubated 
because, as reported in the accompanying paper (22), 
changes in liver composition (i.e., glycogen and tri­
glyceride content) were small. 
Differences between treatment means for all variables 
were tested by using orthogonal comparisons (11, p. 237). 
'Glucostat, Worthington Biochemicals, Freehold, NJ. 
130 
RESULTS AND DISCUSSION 
Kinetics o£ glucose metabolism in the steers were 
determined during this experiment and are reported, along 
with metabolite concentrations in plasma and liver, in 
( 2 2 ) .  
Rates of gluconeogenes is and oxidation of gluconeogenic 
substrates 
Effects of BDP treatment and of fasting on gluconeo­
genic rates and substrate oxidation rates in liver slices 
incubated in vitro are shown in Table 1. Alanine was not 
used as a substrate in the second control period (control 
II) because tissue was limited. Glycerol was used as a 
substrate in the first control period (control I); how­
ever, poor separation of i*C-glycerol from i*C-
glucose by anion-cation exchange chromatography caused extremely 
high background counts. Subsequently, following incuba­
tion with liver, ^ C^-glycerol in the media was phospor-
ylated by using glycerolkinase and ATP, thereby allowing 
separation of the negatively charged ^^ C-glycerol-S-
phosphate from ^^ C-glucose. 
Incorporation of propionate, lactate, alanine, and 
glycerol into glucose by liver slices was greater during 
BDP treatment than during the control periods, but the 
Table 1. Effects of 1,3-butanediol and phlorizin treatment and fasting on in 
vitro gluconeogenesis and substrate oxidation in liver slices from 
steers 
Treatment 
Gluconeogenic 
substrate Control I 
BDP 
(day 14) 
BDP 
(day 28) Control II Fasted 
Standard 
error 
nmoles substrate converted/(100 mg liver x 2 h) — 
Propionate: 
to glucose 
to COz^  
466^ 
83^ ® 
1740®^  
191^  
1143^ ® 
161®f 
467^  
62^  
2400^  
404® 
147 
20 
Lactate: 
to glucose 124^  884® 635^ ® 271^  2452^  141 
to CO 2 286^ ® 476® 317^ ® 213^  789^  40 
Alanine:^  
to glucose 59^  203^  99** 444® 37 
to CO 2 108^  116^  60^  252® 18 
Glycerol: 
to glucose 1312^  834^ ® 411® 1155^ ® 129 
to CO2 31^  86® 91® 31^  99® 7 
I^ncorporation into glucose expressed as nmoles substrate converted to 
glucose/(100 mg liver x 2 h). 
O^xidation to COg expressed as nmoles substrate to C02/(100 mg liver x 2 h). 
R^efer to text for explanation of missing values. 
d,e,f,gMeans in rows with different superscript letters differ (P<.05). 
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increases were significant only for propionate, lactate, 
and glycerol on day 14 of BDP treatment. Mills et al. 
(28) reported that BD caused decreases and P caused in­
creases in gluconeogenic capacity of steer liver slices. 
When BD and P were given in combination, however, the 
inhibitory effects of BD were negated by the stimulatory 
effects of P, resulting in greater rates of gluconeo-
genesis, compared with controls. Effects of P on hepatic 
gluconeogenic enzyme activities are not known fully, 
however, effects of BD have been studied extensively. 
Mehlman et al. (25) reported that pyruvate carboxylase 
(PC) and phosphoenoIpyruvate carboxykinase (PEPCK) 
activities increased in liver and kidney of rats fed BD. 
If these enzymes were affected similarly in steers fed BD, 
it could explain the increases in incorporation of 
propionate, lactate, and alanine into glucose, but not of 
glycerol, because this substrate bypasses the PC and 
PEPCK reactions by entering the gluconeogenic pathway as 
a triose phosphate. 
Data regarding effects on hepatic metabolism of 
spontaneous ketosis in cows are limited. Mills (26) re­
ported that gluconeogenic capacity of liver slices was 
decreased when lactating cows became ketotic. Hibbitt and 
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Baird (12) found that liver slices from ketotic cows had 
respiration rates that were 35% lower than liver slices 
from normal cows. 
Gluconeogenic capacity of liver slices increased 
markedly with all substrates when steers were fasted 
(Table 1) and, with the exception of glycerol, incorpora­
tion of substrates into glucose was greater during fasting 
than during BDP treatment. Mills et al. (28) reported 
increases of in vitro gluconeogenic capacities and 
oxidation rates in liver slices from feed-restricted 
steers. But other reports (14, 19) involving ruminants 
have indicated that in vitro hepatic gluconeogenic 
capacity decreased in response to fasting. Effects of 
fasting on activities of gluconeogenic enzymes have been 
studied extensively. Baird et al. (3) reported that the 
activities of pyruvate kinase and PEPCK in livers of 
starved cows were much less than in livers of fed cows. 
Young et al. (38), however, reported little change in 
activity of PEPCK when cattle were fasted. Another report 
(4) noted that fasting caused a 26% decrease in propionyl-
CoA carboxylase activity in livers of cows. Ballard et al. 
(5) found increased PC activity in fasted cows, compared 
with fed, nonlactating cows. In work with nonruminants 
(29, 31, 32), in vitro hepatic gluconeogenic capacity 
increased in response to fasting. 
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As reported in (22), increases of in vivo glucose 
irreversible loss (IL) were observed in these steers 
during BDP treatment. The BDP-induced increases of in 
vitro hepatic gluconeogenic capacities may explain the 
BDP-induced increases in glucose IL, suggesting that in 
vitro observations were representative of in vivo con­
ditions. We also reported (22) that glucose IL decreased 
when steers were fasted. The fasting-induced increases 
of in vitro hepatic gluconeogenic capacities are not 
consistent with the fasting-induced decreases in glucose 
IL in vivo. But one would not expect to find a concomitant 
decrease for in vitro gluconeogenic capacity and for in 
vivo glucose IL during fasting because gluconeogenic 
substrates were limited in vivo, but not in vitro. 
Lindsay (20) reported that hepatic gluconeogenic rate is 
related more to nutrient supply than to changes in 
efficiency of nutrient utilization. 
Oxidation of propionate, lactate, and glycerol to CO2 
by liver (Table 1) was greater during BDP treatment 
than during the control periods. Oxidation of alanine, 
however, increased only slightly on day 14 of BDP treat­
ment and then decreased below its control value on day 
28 of BDP treatment. 
Oxidation of propionate, lactate, and alanine to CO2 by 
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liver from fasted steers was markedly greater than 
when steers received either control or BDP treatments. 
But with glycerol, oxidation rates during fasting were 
similar to rates during BDP treatment, however, values 
during fasting were greater than control values. In­
creases in substrate oxidation rates during BDP and fast­
ing paralleled the increases in gluconeogenic rates, 
however, the magnitude of the increases were usually 
greater for gluconeogenesis than for oxidation. The 
concomitant increases in gluconeogenic and oxidation 
capacities in liver slices during BDP treatment and fasting 
suggest that gluconeogenic substrates were not utilized 
preferentially either for glucose synthesis or for 
oxidation. Therefore, it seems that the BDP- and fasting-
induced increases in hepatic metabolism were of a general 
nature rather than specific. 
Gluconeogenic capacities and substrate oxidation 
rates were greater on day 14 of BDP than on day 28 of BDP, 
except when glycerol was the substrate, when oxidation 
rates were nearly equal. Although these decreases were 
not statistically significant, they suggest that an 
adaptation in utilization of substrates by liver may have 
begun to occur during prolonged BDP treatment, with 
metabolic capacities shifting back toward control values. 
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Effects of Ca**, ketone bodies, and fatty acids on 
gluconeogenesis 
Effects of Ca**-free buffer and additions of ketone 
bodies, fatty acids, defatted BSA, NAD^ , and niacin on 
in vitro hepatic gluconeogenic capacity are in Table 2. 
When stearate was added to incubation media, Ca** was 
omitted from the buffer solution to prevent formation of 
insoluble Ca^ -^stearate salts. Because Ca**-free buffer 
was used when stearate was added, Ca** also was omitted 
when octanoate, ketone bodies, and BSA were added, so 
that valid comparisons could be made. When the buffer did 
not contain Ca**, incorporation of propionate into 
glucose was not increased by BDP treatment or fasting and 
incorporation of lactate into glucose was not affected by 
BDP treatment, and was increased only slightly by fasting. 
But when the buffer contained Ca** (2.5 mM], incorporation 
of both propionate and lactate into glucose during BDP 
treatment and fasting was much greater than incorporation 
during the control period. We are not aware that anyone 
previously has reported a major differential effect of 
Ca** upon gluconeogenesis between liver slices from two 
different physiological conditions. This intriguing 
observation should be investigated further until an 
explanation is found. 
Table 2. Effects of Ca -free buffer and additions of ketone bodies, fatty 
acids, BSA, NAD , and niacin on in vitro gluconeogenic capacity of 
liver slices from steers 
Flask 
contents 
Substrate 
Propionate 
BDP Control 
II (day 28) Fasted 
Lactate 
Control 
II Cday 28) Fasted 
KRB®:Without Ca** 
With Ca ++ 
KRB without Ca*^  plus: 
Ketone bodies 
3-hydroxybutyrate 
Acetoacetate 
Stearate-BSA 
Ketone bodies plus 
Stearate-BSA 
-/(lOO mg liver X 2 h)-
530^ 4 486®^  646^  263^  336dxy 
467^ 4% 1143^ * 2400cy 271^ * 635^ * 
403^ 4% 637dexy gio^ y 380^ * 213^ * 
gl^ cdx 640d*x 1340^ y 
750^ * 273^ 8/ 578dxy 
35®* 182* 967^ / gdX gex 
31*% 258% 1118^ / lodx 4®* 
508 
2452 
dy 
cy 
dy 581 
526^  ^
183^ ? 
BSA 372^ * 205^ 8* 1215^  ^
Octanoate 599^  ^ 817^  998^  
KRB with Ca** plus: 
NAD+ 2929^  
Niacin 3082= 
a Krebs-Ringer bicarbonate buffer. 
'^g-hydroxybutyrate and acetoacetate, each 5 mM. 
G,d,e,f,g^ gg^ g in columns with different superscript letters differ (P<.05). 
*'^ For each substrate, means in rows with different superscript letters 
differ (P<.05). 
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Although effects of Ca on in vitro gluconeogenic 
capacity of liver from ruminants have not been reported 
previously, effects of other ions have been reported. Leng 
and Annison (19) indicated that incorporation of propionate 
into glucose by sheep liver slices was favored by in­
creased Na^  and decreased content in incubation media. 
Kimmich and Rasmussen (15) reported that 100 mM Ca** 
additions to incubation media inhibited PC activity in 
isolated mitochondria of rat liver, indicating that Ca** 
may play an important role in regulating the initial 
reactions of gluconeogenesis. Although Ca*t has been 
shown to inhibit magnesium-activated enzymes (7), our data 
indicate that capacities for gluconeogenesis and substrate 
oxidation in liver slices were enhanced by Ca** during 
BDP treatment and fasting, possibly suggesting an increase 
in the activities of enzymes associated with the gluco­
neogenic and tricarboxylic acid cycle pathways. 
Additions of BHBA plus ACAC to Ca**-free buffer (Table 
2) did not significantly affect incorporation of pro­
pionate and lactate into glucose. Addition of BHBA (5 mM) 
to Ca**-free buffer increased incorporation of propionate 
into glucose in all treatment periods, but despite in­
creases of up to two fold, effects were not significant. 
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Addition of ACAC (5 mM) caused gluconeogenesis from 
propionate to increase slightly during the control period, 
however, values tended to decrease when ACAC was added to 
liver obtained from BDP-treated and fasted steers. With 
the possible exception of BHBA addition to liver from 
fasted steers, it seems that ketone bodies, either 
separately or in combination, had no effect on hepatic 
gluconeogenesis from propionate. Krebs et al. (16) re­
ported that ACAC promoted glucose synthesis in rat kidney 
cortex slices by serving as a fuel for respiration, thereby 
sparing gluconeogenic precursors from oxidation, and by 
activating pyruvate carboxylase via increased acetyl CoA 
formation from ACAC. 
Addition of 1 mM stearate bound to BSA (Table 2) 
essentially stopped (93% reduction) incorporation of 
propionate and lactate into glucose during control and 
BDP periods. But in liver slices prepared from fasted 
steers, stearate-BSA did not inhibit incorporation of 
propionate and lactate into glucose. Thus, the liver 
slices from fasted steers again show a differential re­
sponse. No previous data regarding the effects of LCFA 
on in vitro gluconeogenesis in liver from ruminants are 
available, however, data presented here indicate that 
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stearate-BSA is a potent inhibitor of gluconeogenesis 
from propionate and lactate, except in liver from fasted 
steers. 
Addition of ketone bodies and stearate-BSA in com­
bination (Table 2) caused marked reductions in incorpora­
tion of propionate and lactate into glucose during control 
and BDP periods. But in liver slices obtained from fasted 
steers, ketone bodies plus stearate-BSA did not inhibit 
gluconeogenesis from propionate or lactate, although a 
nonsignificant decrease in incorporation of lactate into 
glucose was seen. Additions of ketone bodies plus 
stearate-BSA caused effects similar to those seen when 
stearate-BSA was added alone. Therefore, it seems that 
under the conditions reported here, ketone bodies per se 
do not significantly affect incorporation of propionate 
or lactate into glucose by liver slices prepared from 
control, BDP-treated, or fasted steers. The curious 
response of liver slices from fasted steers is again 
evident when ketone bodies plus stearate-BSA is present. 
Because LCFA are insoluble in aqueous solutions 
(plasma, KRB buffer) at pH 7.4, they must be bound to 
protein. To determine if the BSA component of the 
stearate-BSA complex affected gluconeogenic rates, liver 
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slices were incubated in Ca**-free KRB buffer containing 
3% defatted BSA. Incorporation of propionate into glucose 
decreased by 30% and 58% (Table 2) when BSA was added to 
media containing liver slices from control and BDP-treated 
steers, however, the decreases were not significant. These 
data indicate that, although BSA may cause a slight de­
crease in gluconeogenesis from propionate, most of the 
inhibition caused by the stearate-BSA complex can be 
attributed to stearate. Schimmel and Knobil (32) found that 
defatted BSA did not affect gluconeogenesis from pyruvate 
in rat liver slices. Incorporation of propionate into 
glucose increased by 88% (Table 2) when BSA was added to 
liver slices prepared from fasted steers, which was 
similar to the increases noted when stearate-BSA and ketone 
bodies plus stearate-BSA were added. Although these in­
creases were not significant, it seems that BSA additions 
may stimulate in vitro gluconeogenesis from propionate in 
liver slices from fasted steers. 
Octanoate was added (1 mM) to incubation media to 
determine the effects of a medium-chain, water soluble 
fatty acid on gluconeogenesis from propionate (Table 2). 
Octanoate caused a small increase in incorporation of 
propionate into glucose by liver slices prepared during 
the control treatment. But during BDP treatment and 
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fasting, octanoate caused more marked increases in gluco-
neogenesis from propionate, however, the increases were 
significant only during BDP treatment. Clark et al. (6) 
reported that butyrate, a short-chain fatty acid, in­
creased gluconeogenic capacity of isolated lamb liver 
cells. Leng and Annison (19) reported similar findings 
from liver slices from starved sheep, but with fed sheep, 
butyrate did not affect hepatic gluconeogenesis. 
Effects of niacin and NAD"*' on gluconeogenesis 
Niacin is effective in the treatment of bovine 
lactation ketosis (10) and has been shown to have an anti-
lipolytic effect in cattle (35). The effects of supple­
mental niacin on carbohydrate metabolism in ruminants 
are not known fully. Because niacin promotes an increase 
in blood glucose (34), workers have speculated, however, 
that niacin potentiates gluconeogenesis in the 
ruminant. It is possible that the therapeutic actions of 
niacin may be mediated through NAD^  and NADP^ , important 
coenzymes involved with carbohydrate and lipid metabolism, 
of which niacin is a component. 
Sufficient liver was obtained from the biopsy at the 
end of the fasting period to allow additions of NAD^  and 
niacin to liver slice incubations to determine if either 
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compound affected gluconeogenesis from propionate. Ad­
dition of NAD* (.45 mM) to KRB containing Ca** caused 
incorporation of propionate into glucose to increase by 22% 
and addition of niacin (.50 mM) caused values to increase 
by 28%, when compared with controls (KRB with Ca**), but 
the increases were not statistically significant (Table 2). 
Concentration of NAD* in liver of normal and fasted cows 
is approximately 1.1 and .56 mM (3), therefore, our NAD* 
additions were not in excess of physiological concentra­
tions. NAOt in liver was not measured in this experiment. 
It is possible that NAD* was decreased in liver of fasted 
steers, thereby limiting availability of NAD* for gluco­
neogenesis, which would explain why NAD* additions caused 
higher rates of gluconeogenesis from propionate. The 
slight niacin-induced increase in gluconeogenesis indicates 
that either the vitamin itself may have been stimulatory 
or that liver slices utilized the excess niacin to 
synthesize more NAD*. In either case, provided the niacin-
induced increase was real, it seems that these observations 
in vitro support the observations that niacin promotes 
increases in blood glucose concentrations in vivo. 
Factors affecting substrate oxidation 
Data on effects of Ca**-free buffer and additions 
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of ketone bodies, fatty acids, defatted BSA, NAD^ , and 
niacin on substrate oxidation rates in vitro are 
summarized in Table 3. Omission of Ca** from KRB buffer 
and additions of ketone bodies, either in combination or 
alone, did not cause any consistent changes in oxidation 
of propionate or lactate. Addition of stearate-BSA, alone 
and in combination with ketone bodies, caused oxidation 
rates to decrease. When propionate was the substrate, 
BSA caused decreased oxidation rates, however, octanoate, 
NAD^  and niacin additions did not cause any marked changes. 
Overall, effects of in vitro additions on substrate 
oxidation were, in most cases, similar to effects observed 
on gluconeogenic capacity of liver slices (Table 2). 
Concentrations of glucose in incubation media (see 
appendix) and rates of substrate oxidation were correlated 
with gluconeogenic rates (Table 4). Positive correlations 
were found between media glucose and gluconeogenic rates, 
with a possible exception occurring when lactate was the 
substrate, when probability only approached .05. Positive 
correlations indicate that increases in gluconeogenic 
rates were associated with increases in media glucose 
concentration. Sources of glucose in incubation media 
include free glucose in liver, glucose released from liver 
Table 3. Effects of Ca -free buffer and additions of ketone bodies, fatty 
acids, BSA, NAD , and niacin on in vitro substrate oxidation by liver 
slices from steers 
Substrate 
Propionate Lactate 
Flask 
contents 
Control BDP 
II (day 28) Pasted 
Control BDP 
II (day 28) Fasted 
KRB*: Without Ca ++ 
With Ca** 
KRB without Ca*. plus: 
Ketone bodies 
3-hydroxybutyrate 
Acetoacetate 
Stearate-BSA 
Ketone bodies plus 
Stearate-BSA 
164 
6 2  
ex 
cdx 
nmoles substrate oxidized to CO2 
/(lOO mg liver x 2 hr) 
116 
161 
cx 
cx 
4i»cdy 
404=4/ 
382' 
213 cx 
245 
317 
ed 
cx 
322" 
789^  ^
173®* 257^ * 531=*? 472<ixy 222^ % 591=? 
203®* I75CX 650®? 
345fxy 120^ * 4ncdy 
22^ * 15®* 24ldy 27®* 22®* 348^ / 
27CX 27®* 38lCdy 43®* 33®* 197^ ? 
38^ % 48®* 255^ 7 
Ijjdex iggcx 432^ 4? 
495^ ® 
579^ ® 
K^rebs-Ringer bicarbonate buffer. 
3^-hydroxybutyrate and acetoacetate, each 5 mM. 
c,d,e,f^ gg^ g in columns with different superscript letters differ (P<.05). 
*'^ For each substrate, means in rows with different superscript letters 
differ (P<.05). 
BSA 
Octanoate 
KRB with Ca** plus: 
NAD+ 
Niacin 
Table 4. Correlation coefficients for media glucose vs. gluconeogenic rate and 
substrate oxidation rate vs. gluconeogenic rate in liver slice 
incubations 
Substrate 
Correlation coefficients and 
level of significance 
Media glucose vs. 
gluconeogenic rate 
Substrate oxidation rate 
P>R vs. gluconeogenic rate P>R 
Propionate 
Lactate 
Alanine 
Glycerol 
.48 
.23 
.39 
.91 
. 0001  
.092 
. 0 0 8  
. 0001  
.89 
.84 
.92 
.74 
.0001 
.0001 
.0001 
.0001 
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glycogen by phosphorolytic and hydrolytic cleavage, and 
gluconeogenesis by liver slices. 
Glucose effectively suppresses gluconeogenesis in 
vivo (1). Seto et al. (33) reported that glucose 
formation from propionate was reduced by 10 mM glucose in 
vitro. In the present experiment, glucose in media did 
not exceed 2 mM; therefore, gluconeogenesis should not 
have been inhibited by high concentrations of glucose. 
Positive correlations between gluconeogenic rates and 
media glucose concentrations substantiate the lack of 
glucose inhibition. 
Substrate oxidation rates were correlated positively 
(Table 4) with gluconeogenic rates (data from Table 1), 
indicating that gluconeogenic substrates were not 
preferentially utilized for either glucose synthesis or 
oxidation during BDP- or fasting-induced increases in 
hepatic metabolic rates. This lack of preference suggests 
that effects of BDP treatment and fasting on capacities 
of hepatic enzymes were not specific, i.e., enzymes of 
both the gluconeogenic pathway and the tricarboxylic 
acid cycle were affected. 
Ketogenesis and oxidation of ketogeiiic substrates 
Ketogenic capacities and substrate oxidation rates. 
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as affected by BDP treatment and fasting, are summarized 
in Table 5. Production of BHBA during the first control 
period (control I) is not reported because BHBA concen­
tration in media were not determined. In these samples. 
Universal Indicator^  was used to show neutral pH during 
titration with KOH. It was discovered later that the 
indicator interferred with enzymatic determination of 
BHBA. Subsequently, indicator sticks® were used to show 
neutrality. 
Net BHBA production and substrate oxidation rates 
were greater from butyrate than from palmitate, regard­
less of treatment. Greater rates of BHBA production 
from butyrate may be caused by selective entry into mito­
chondria. Butyrate freely enters mitochondria, but 
palmitate requires the carnitine acyltransferase (CAT) 
system for entry. The CAT system plays an important 
role in regulation of hepatic fatty acid oxidation and 
hence of ketogenesis (36). Net BHBA production from 
"^ Fisher Universal Indicator Solution, Fisher 
Scientific Co., Fairhaven, NJ. 
®Color pHast indicator sticks (pH 0-14), MCB 
Reagents, Gibbstown, NJ. 
Table 5. Effect of 1,3-butanediol and phlorizin treatment and fasting on in 
vitro ketogenesis and substrate oxidation in livèr slices from steers 
Treatment 
Ketogenic 
substrate 
Control 
I 
BDP 
(day 14) 
BDP 
(day 28) 
Control 
II Fasted 
Standard 
error 
Butyrate*: 
BHBA produced^  
Substrate oxidized* 266' 
1051' 
137* 
655 
143* 
cd 414' 
154* 
650r 
292* 
83 
21 
Palmitate: 
BHBA pro. 
Substrate oxidized 3 2.9 3.3 2.4 3.3 .1 
duced --- 71*^  37^  12^ ® 3® 7 
*Refer to text for explanation of missing values. 
n^moles/(100 mg liver x 2 h). f 
*''^ '®Means in rows with different superscript letters differ (P<.05), 
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butyrate in liver slices was significantly greater on 
day 14 of of BDP treatment than during the control period, 
however, values on day 28 of BDP and during fasting were 
only 60% greater than controls. Production of BHBA from 
palmitate was significantly greater on day 14 of BDP 
treatment than during the control period. By day 28 of 
BDP, however, values decreased, but were still 3-fold 
greater than controls. In liver slices prepared from 
fasted steers, BHBA production from palmitate was lower 
than controls, but the difference was not significant. 
With both butyrate and palmitate, the measured 
ketogenic capacity of liver slices was greatest on day 14 
of BDP treatment and an adaptation in utilization of 
ketogenic substrate by liver had occurred during prolonged 
BDP treatment, causing ketogenic capacity on day 28 of 
BDP to approach control levels. A similar adaptation was 
noted for utilization of glucogenic substrates for 
gluconeogenesis (Table 1). Mills et al. (28) reported 
that in vitro hepatic ketogenic capacity was not affected 
by short-term BDP treatment in steers. Ketogenic 
capacity of liver slices was depressed markedly when 
lactating cows became ketotic (26) and ketogenic capacity 
of rat liver homogenate was not affected by starvation 
and subsequent ketonemia (24). 
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Oxidation of butyrate to CO2 by liver slices was 
highly variable during the control periods, thereby making 
comparisons with BDP and fasting periods difficult. But 
it is apparent that oxidation of butyrate was greater 
during fasting than during BDP treatment. Oxidation of 
palmitate to CO2 by liver slices was minimal and not 
affected by BDP treatment or fasting. The increased 
capacity for beta oxidation when butyrate, rather than 
palmitate, was the substrate suggests that regulation 
occurred prior to beta oxidation, probably at the CAT 
system. 
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GENERAL DISCUSSION 
During the control and BDP periods, feed intake was 
constant, therefore, effects of ketonemia-glucosuria on 
hepatic metabolism are not confounded with variations in 
feed intake. During the early stages of spontaneous 
ketosis, cows exhibit normal behavior, however, as the 
disease progresses, they soon become hypophagic. There­
fore, in ketotic cows or in a starvation ketosis, effects 
of ketonemia on hepatic metabolism are confounded with 
effects of reduced feed intake. 
The physiological status of these steers (i.e., keto­
nemia-glucosuria and fasting) markedly affected hepatic 
glucose synthesis from propionate, lactate, alanine, 
and glycerol (Table 1). BDP treatment effectively caused 
an increase in the gluconeogenic capacity of liver slices, 
and because BDP caused ketonemia (22), it seems that 
ketonemia in vivo does not inhibit, and may even stimulate, 
in vitro gluconeogenesis. Whether ketonemia affects in 
vivo hepatic gluconeogenesis is not known, but reports 
(17, 18) indicate that glucose irreversible loss is not 
affected during the early stages of spontaneous ketosis 
when cows exhibit normal feeding behavior. The BDP-
induced increases of substrate incorporation into glucose 
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cannot be attributed solely to increases in PC and PEPCK 
activities because incorporation of glycerol into glucose 
increased also during BDP treatment. BDP also increased 
oxidation of glucogenic substrates by liver slices (Table 
1), suggesting that ketonemia-glucosuria not only affected 
gluconeogenic enzymes, but also affected enzymes involved 
in the tricarboxylic acid cycle. 
It seems that the maximal effects of BDP treatment 
on in vitro hepatic gluconeogenic and ketogenic 
capacities occur within 14 days and that continuation of 
BDP treatment does not promote greater changes. Data 
presented in (22) indicate that changes in blood and 
liver metabolite concentrations were maximal by day 14 of 
BDP treatment. 
Incorporation of substrates into glucose and 
oxidation of gluconeogenic substrates to CO2 were increased 
markedly by fasting (Table 1), suggesting that decreased 
supply of dietary gluconeogenic substrates in vivo either 
directly or indirectly caused hepatic enzyme activities 
to increase. As with BDP treatment, it seems that fast­
ing not only increased capacities of gluconeogenic 
enzymes, but also increased capacities of tricarboxylic 
acid cycle enzymes, as evidenced by greater rates of 
substrate oxidation. Therefore, the fasting-induced 
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increases in hepatic metabolic rates appear to be 
general. 
The absence of Ca** in incubation media eclipsed 
the BDP- and fasting-induced increases in hepatic gluco-
neogenesis (Table 2), thereby suggesting that Ca** may 
either directly or indirectly affect hepatic gluconeo-
genesis in ruminants. It is possible that Ca** may be 
required for increases in activities of gluconeogenic 
enzymes to occur, or that Ca** may allow greater entry of 
substrates into hepatocytes for gluconeogenesis. Further 
studies may determine whether the Ca** effects are an 
artifact of in vitro tissue incubations or are of any 
physiological significance. 
Stearate-BSA effectively inhibited incorporation of 
propionate and lactate into glucose (Table 2) and oxida­
tion of these substrates to CO2 (Table 3) by liver slices 
prepared from control and BDP-treated steers. As with 
BDP treatment and fasting, it seems that the inhibitory 
effects of stearate-BSA were general, rather than enzyme-
specific. The effects of stearate-BSA additions in 
vitro may be of physiological significance, because FFA 
concentrations in plasma of ketotic cows often exceed 1 mM 
and may be at least partly responsible for the decrease 
seen in glucose irreversible loss during the advanced 
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stages of spontaneous ketosis. But it is possible also 
that effects of protein-bound LCFA on gluconeogenesis and 
substrate oxidation in vitro can be attributed entirely 
to the unphysiological conditions associated with in 
vitro tissue incubations. The lack of stearate-induced 
inhibition of gluconeogenesis and substrate oxidation in 
liver slices prepared from fasted steers is in contrast 
to observations made during the control and BDP periods. 
It is possible that the mechanisms responsible for the 
fasting-induced increases in gluconeogenesis negated the 
inhibitory effects of stearate-BSA. 
As discussed in (22), other than causing ketonemia-
ketonuria, it seems that 1,3-butanediol has no adverse 
effects on metabolism in cows. But the physiological 
effects of phlorizin may not be limited to its effects on 
transport of glucose across cell membranes. Phlorizin 
has been shown to inhibit activity of glucose-6-phospha­
tase in rabbit intestine (21). Zanobini et al. (39) 
reported that P did not inhibit activities of purified, 
commercially prepared enzymes involved in glucose 
metabolism in vitro; however, P did inhibit the enzymes 
in rat kidney in vivo. Results from our laboratory, 
however, do not indicate that treatment in vivo with P 
causes inhibition of gluconeogenic enzymes. When liver 
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slices prepared from P-treated steers were incubated with 
gluconeogenic substrates, rates of incorporation of 
substrates into glucose tended to increase (28). Data 
presented in Table 1 indicate that when P is given in 
combination with BD in vivo, rates of incorporation of 
substrate into glucose increased. Previous reports (23, 
28} and data presented here suggest that 1,3-butanediol 
and phlorizin, given at amounts reported herein, cause no 
physiological perturbations other than ketonemia, 
ketonuria, and glucosuria. 
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GENERAL SUMMARY 
The primary objective of this dissertation project was 
to evaluate the efficacy of 1,3-butanediol and phlorizin 
for causing an induced ketosis in steers. Physiological 
effects of BDP treatment in steers were compared with 
reported effects of ketosis in lactating cows to determine 
if the physiological stress created by BDP treatment is as 
severe as that imposed by lactation. 
In the first trial (Section I), when BD was fed 
for 14 days and P was injected during the last 7 days of 
BD feeding, glucosuria and ketonuria were evident, 
concentrations of glucose in plasma decreased, and concen­
trations of ketone bodies and FFA increased. The changes, 
however, were not as great as those occurring in lactating, 
ketotic cows. Treatment with BDP did not cause 
significant changes in concentrations of insulin, glucagon, 
or growth hormone in plasma (4) or in concentrations of 
glycogen and triglyceride in liver (6), which also 
indicated that the physiological stress in steers treated 
with BDP was not as great as that in lactating cows. 
When steers received BDP, glucose IL, glucose pool 
size, and glucose space were greater than when steers 
received the control treatment. The increase in glucose 
164 
IL suggests that hepatic gluconeogenesis increased in 
response to urinary glucose excretion and that, under normal 
physiological conditions, gluconeogenic capacity of liver 
is not utilized fully in steers. The amount of glucose 
excreted in urine was similar to the increase in glucose IL 
during BDP treatment, indicating that steers maintained 
glucose homeostasis. Mills et al. (6) reported that in 
vitro gluconeogenic capacity of liver slices prepared from 
steers receiving BDP was greater than that in steers during 
the control period, which may explain how glucose IL in­
creased in vivo. 
Because physiological perturbations in steers 
receiving the 14-day BD, 7-day F treatment were not as great 
as those in cows during lactation ketosis, the length of 
treatment with both BD and P was increased to 28 days 
(Sections II and III) in an attempt to cause greater 
changes in blood and liver metabolite concentrations. In 
addition, effects of a 9-day fast (Sections II and III) 
on blood and liver metabolite concentrations and on 
glucose IL also were determined to see if the physiological 
stress of BDP treatment was comparable to that of fasting. 
Treatment with BDP for 28 days did not cause changes 
in blood or liver metabolite concentrations or. glucose IL 
greater than those caused by short-term BDP treatment. 
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suggesting that physiological adaptations to ketonemia-
glucosuria in steers occurred rather rapidly (i.e., within 
14 days) and that, despite glucosuria, glucose homeostasis 
was maintained. The physiological stress imposed by fasting 
was greater than that imposed by extended BDP treatment, as 
evidenced by lower concentrations of liver glycogen and 
higher concentrations of plasma FFA during fasting. Even 
after fasting, however, plasma glucose concentrations 
were still 85% of control values, but glucose IL was only 
50% of control values. The slight decrease in plasma 
glucose during the marked decrease in glucose IL suggests 
that homeostatic mechanisms spared glucose from oxidation 
in order to maintain plasma glucose concentrations at 
physiological concentrations. It is likely that ketone 
bodies, FFA, and amino acids served as alternate energy 
sources during fasting. 
In addition to determining in vivo effects of BDP 
treatment and fasting, effects on in vitro hepatic gluco-
neogenesis and ketogenesis also were determined. BDP 
treatment and fasting both caused greater rates of in­
corporation of propionate, lactate, alanine, and glycerol 
into glucose, and the increases for fasting were greater 
than those for BDP treatment. Mills et al. (6) reported 
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previously that, compared with control steers, in vitro 
hepatic gluconeogenic capacity was greater when steers 
received BDP or were fasted. The mechanisms by which 
hepatic gluconeogenesis increased in response to BDP and 
fasting are not known. It is possible that capacities of 
gluconeogenic enzymes were increased by BDP and fasting, 
however. Young et al. (7) reported that PEPCK activity in 
liver of cattle was not affected by fasting. Other reports 
have indicated that in vitro hepatic gluconeogenic capacity 
(1) and activities of PEPCK (2) and propionyl-CoA carboxy­
lase (3) decreased in response to fasting in cattle. 
Therefore, it seems that effects of fasting on gluconeo­
genesis in ruminants are not known fully. 
Rates of oxidation of butyrate and palmitate to BHBA 
were increased by BDP treatment, but fasting did not cause 
any changes. Butyrate was oxidized at a much greater rate 
than palmitate, suggesting that entry of substrates into 
mitochondria is selective. Mills (5) reported that neither 
BDP treatment nor fasting had an effect on rates of hepatic 
ketogenesis. 
In ketotic cows, concentrations of ketone bodies and 
FFA in blood are elevated greatly above normal. The effects 
of ketone bodies and FFA on hepatic gluconeogenesis in 
ruminants are not known; therefore, both were added to in 
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vitro liver slice incubations to determine if hepatic 
gluconeogenic capacity was affected. In addition, effects 
of omission of Ca** from incubation media on hepatic 
gluconeogenesis were determined also. 
In vitro additions of ACAC (5 mM) and BHBA (5 mM) did 
not significantly affect gluconeogenic capacity of liver 
slices prepared from steers receiving the control, BDP, 
or fasting treatments. Therefore, it is possible that 
ketonemia (ketone bodies) during ketosis does not directly 
affect hepatic gluconeogenesis in vivo. In vitro additions 
of stearate (1 mM) bound to bovine serum albumin greatly 
reduced gluconeogenic capacity of liver when steers received 
the control or BDP treatments, but values tended to in­
crease for liver slices from fasted steers. Whether LCFA 
affects gluconeogenesis in vivo in ruminants is not known 
and it is possible that the effects of LCFA reported in this 
study are artifacts of the in vitro system. The dif­
ferential effect of LCFA on gluconeogenesis during fasting 
cannot be explained by results of this study. 
When Ca** was omitted from incubation media, gluco­
neogenesis from propionate and lactate was not affected 
when liver slices were from control steers. But during 
BDP treatment and fasting, omission of Ca** caused large 
decreases in incorporation of substrates into glucose by 
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liver slices. Effects of Ca on in vitro hepatic gluco­
neogenic capacity in ruminants have not been reported 
previously, however, results of this study suggest that, 
under some conditions, Ca** may play an important role in 
regulating gluconeogenesis. 
Studies of the effects of lactation on intermediary 
metabolism have provided researchers with a basic under­
standing of the etiology of ketosis, however, the effects 
of ketonemia, hypoglycemia, and elevated plasma FFA 
during ketosis on intermediary metabolism are not known 
fully and further study is needed. Continued improvements 
in management, feeding, and breeding of dairy cattle will 
result in additional increases in milk production and, 
because high-producing cows are more susceptible to ketosis, 
the incidence of the disease likely will increase in the 
future. 
Research in bovine lactation ketosis is difficult be­
cause of the lack of a predictable supply of ketotic cows. 
Just as the development of the alloxan-diabetic rat has 
allowed great advances in understanding human diabetes, 
development of a valid experimental ketosis model should 
allow for major advances in understanding lactation ketosis. 
Further attempts, therefore, should be made to develop a 
suitable ketosis model. Although the current BDP model of 
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ketosis in steers does not fully simulate the physiological 
conditions in the ketotic cow, it will still be of value 
in the study of intermediary metabolism in ruminants that 
are affected by ketonemia and glucosuria. 
Results of this study created more questions than 
were answered, but this is a common characteristic of 
basic research. Further attempts should be made to im­
prove the BDP ketosis model. Improvement possibly could 
be accomplished by using overconditioned steers abruptly 
changed to maintenance or submaintenance rations at the 
initiation of BDP treatment. Overconditioned cows are 
more susceptible to lactation ketosis; therefore, over-
conditioned steers may be more susceptible to experimental 
ketosis. Other suggestions for future research include: 
1. Determine why omission of Ca** from incubation 
media negated the BDP- and fasting-induced in­
creases in hepatic gluconeogenesis. This may 
best be accomplished by using isolated perfused 
rat liver and by using isolated hepatocytes from 
ruminants. Furthermore, would in vitro 
additions of EDTA to perfusion and incubation 
media, with and without Ca**, cause more marked 
inhibition of hepatic gluconeogenesis? 
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2. Determine why liver slices obtained from steers 
during fasting showed differential responses 
to in vitro additions of stearate-BSA and 
defatted BSA. Is liver of fasted steers 
histologically similar to liver of fed steers? 
Niacin supplementation seems to be beneficial in the 
prevention and treatment of lactation ketosis, supposedly 
by inhibiting lipolysis and by "enhancing carbohydrate 
metabolism". Therefore, investigations into the effects 
of supplemental niacin on kinetics of glucose metabolism 
in vivo and on hepatic gluconeogenic capacity in vitro 
may conclusively determine whether niacin increases hepatic 
gluconeogenesis. If so, then niacin should routinely be 
added to rations of dairy cows. 
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APPENDIX 
Table Al. Effects of in vivo treatments and in vitro additions on amount of 
glucose in incubation media 
Substrate 
Propionate Lactate 
Flask 
contents Control 
BDP 
(day 28) Fasted 
BDP 
Control (day 28) Fasted 
•Mg glucose in incubation media/100 mg liver-
++ 
KRB:without Ça 
with Ca 
KRB without Ca** plus: 
Ketone bodies 
ACAC 
BHBA 
Stearate-BSA 
Ketone bodies plus 
stearate-BSA 
BSA 
Octanoate 
NAD+ 
Niacin 
341 
210 
abc 
ax 
400 
394 
336 
423 
242 
457 
330 
abc 
abc 
abc 
be 
acx 
abc 
543*CY 
442 
294! 
570 
400 
abc 
ab 
572^  
386 
413 
ab 
abx 
520 
346 
620 
447 
502 
396 
389 
422 
402 
be 
a 
ab 
abcx 
ab 
ab 
ab 
ab 
523 
315 
ax 
bx 
,ab 
5I9*Y 
491*bx 297^ ? 342*y 
475* 670^  462' 
571** 432*^ *^ 319*^  ^
*'^ '^ Means in columns with different superscript letters differ (P<.05). 
*'^ For each substrate, means in rows with different superscript letters 
differ (P<.05). 
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Table A2. Coefficients of correlation between amount of 
glucose in incubation media and hepatic gluco­
neogenic rate 
Substrate and 
in vitro addition Correlation P>R 
PRO .48 .0001 
LAC .23 .092 
ALA .39 .008 
GLY .91 .0001 
PRO - no Ca** .63 .0001 
PRO + KB .77 .0001 
PRO + ACAC .72 .0001 
PRO + BHBA .68 .0001 
PRO + stearate .22 .195 
PRO + KB + sterate .40 .015 
PRO + BSA^  -.02 .915 
PRO + NAD .75 .008 
PRO + niacin .77 .004 
LAC - no Ca** .19 .428 
LAC + KB .47 .005 
LAC + stearate .67 .0001 
LAC + KB + stearate -.26 .189 
PRO = propionate, LAC = lactate, ALA = alanine, GLY = 
glycerol, I® = ACAC (5 mM) + BHBA (5 , BSA = defatted 
bovine serum albumin (3% final concentration). 
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Table A3. Coefficients of correlation between in vitro 
hepatic substrate oxidation rate and gluconeo­
genic rate 
Substrate and 
in vitro addition Correlation P>R 
PRO .89 .0001 
LAC .84 .0001 
ALA .92 .0001 
GLY 
No Ca 
.74 .0001 
PRO - .75 .0001 
PRO + KB .75 .0001 
PRO + ACAC .72 .0001 
PRO + BHBA .89 .0001 
PRO + stearate .90 .0001 
PRO + KB + stearate .96 .0001 
PRO + BSA^  .82 .0001 
PRO + NAD .85 .002 
PRO + niaciç^  .99 .0001 
LAC - no Ca .53 .02 
LAC + KB .95 .0001 
LAC + stearate .96 .0001 
LAC + KB + stearate .97 .0001 
*Refer to Table A2 for explanation of abbreviations. 
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ASSAY OF LOW CONCENTRATIONS OF LONG-CHAIN 
FATTY ACIDS IN PLASMA BY FORMING ®'Ni SALTS 
178 
PREFACE 
The section presented herein, "Assay Of Low Concentra­
tions Of Long-Chain Fatty Acids in Plasma By Forming ®®Ni 
Salts", summarizes my attempts to improve the original 
procedure published by Ho (14) titled "Radiochemical Assay 
Of Long-Chain Fatty Acids Using ®^ Ni As Tracer". After 
many months of testing, it was decided that the modified 
radiochemical assay of FFA was reliable, and the procedure 
was used to determine FFA concentrations in plasma in 
Section I of this dissertation. 
Originally, my intention was to submit the modified 
radiochemical assay for publication. But after further 
use of the procedure, it was noted that precision of the 
method began to decrease. Additionally, in measuring 
plasma FFA concentrations, determinations using the ®^ Ni 
assay were compared with determinations using the enzymatic 
method of Shimizu et al. (27) titled "Enzymatic micro-
determination of serum free fatty acids". Correlation 
between the two procedures was low (r = .5) and, because 
the precision of the enzymatic method was much greater 
than that of the ®^ Ni assay, it was decided that the 
modified ®®Ni assay was not worthy of publication. The 
preliminary manuscript, however, was included in this 
dissertation to permanently document my attempts to improve 
the assay. 
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INTRODUCTION 
Ayer (1) reported that Cu, Ni and Co formed chloro­
form- soluble salts with long chain free fatty acids (FFA). 
Colorimetric methods (8, 11, 16, 17, 18, 19, 20, 24, 26) 
for measuring FFA are based on the reaction of diethylthio-
carbamate or diphenylcarbazide with Co or Cu bound to FFA 
in organic solution. Major problems involving colorimetric 
methods include low sensitivity and poor repeatability, 
due partially to contamination of the final extract with 
traces of Co or Cu from the aqueous reagent. In 1969, Ho 
and Meng (15) reported a new method for the quantitative 
measurement of FFA involving a radiochemical assay of 
®°Co-FFA complexes, giving a direct measurement of the molar 
quantity of FFA in plasma or incubation media. The re­
covery of "^Co-FFA complex in the labeling solution was 
100% for FFA with 14 or more carbon atoms. The FFA:Co 
molar ratio in the labeling solution was 2.05 indicating 
that one mole of Co bound approximately two moles of FFA. 
Lactic acid did not interfere with the assay but Ho and 
Meng (15) did not determine if this was the case for other 
plasma metabolites, such as g-hydroxybutyric acid or 
lecithin. 
Ho (14) subsequently modified the ®®Co radiochemical 
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assay by using ®®Ni as the tracer. ®^ Ni is a weak beta 
emitter, is easily counted by liquid scintillation, and 
is safer to use than ®°Co, a high-energy gamma emitter. 
Ho (14) used Dole's extraction mixture (7) to extract FFA 
from plasma. Lactic acid and tripalmitin did not interfere 
with the assay. However, lecithin and cephalin formed a 
chloroform-heptane soluble complex with Ni, thereby 
necessitating the separation of phospholipids from FFA in 
the extraction mixture. The FFA:Ni molar ratio in the 
organic phase following the labeling of stearic acid 
standards was 2.04. 
Marinetti et al. (21) reported that phospholipids 
were first separated on a silicic acid column by D. M. 
Rathmann, who described the procedure in a thesis submitted 
to the University of Rochester in 1944. Since McCarthy 
and Duthie (22) reported that silicic acid binds phos­
pholipids, it has routinely been used to separate FFA from 
phospholipid in organic extract of plasma or tissue samples 
(16, 20). Ho (14) modified the Dole and Meinertz (7) 
FFA extraction procedure by adding silicic acid to the 
organic extract of plasma to bind phospholipids. However, 
reports (3, 11, 14, 26) indicated that silicic acid not 
only binds phospholipids, but also binds FFA. Ho (14) 
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using i^ C-palmitic acid, reported that with 200 mg silicic 
acid per assay, more than 60% of the "^*0 radioactivity was 
not recovered from an unspecified volume of choloroform-
heptane. When Ho used 5 mg silicic acid per 500 yl 
chloroform-heptane, FFA binding to silicic acid was non­
significant. However, for plasma FFA determination. Ho 
used 5 mg silicic acid in 160 ul chloroform-heptane, a 
level which exceeded the silicic acid concentration used 
in the FFA binding test by more than 3 fold. 
Itaya and Ui (18) used phosphate buffer to prevent 
coextraction of phospholipid and FFA from serum. They 
reported that lipid phosphorous extracted by chloroform 
in the presence of phosphate buffer was less than 1.3% 
of the lipid phosphorous extracted by methanol-chloroform. 
Other reports (11, 12, 24) indicated that phosphate buffer 
effectively prevented coextraction of phospholipids and 
FFA from plasma or serum. With colorimetric FFA procedures 
(4, 9, 19, 23, 28), coextraction of phospholipids and FFA 
from plasma is reportedly prevented by the aqueous Co 
or Cu reagent. Noma et al. (25) reported that only 1.7% 
of chloroform-methanol extractable phospholipid was re­
covered in the organic phase when serum FFA was extracted 
in the presence of an aqueous Cu reagent. 
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DeBrabander and Verbeke (6) modified the radio­
chemical assay of Ho (14) by replacing the centrifugation 
step, following FFA labeling using an aqueous solution of 
®^ Ni, with absorption of water using anhydrous sodium 
sulfate. Tracer in aqueous solution not bound to FFA 
was thereby removed from the organic phase. This modifica­
tion caused an increased repeatability and a higher re­
covery of the FFA-Ni complex. However, this modification 
was tested only on solutions of stearic acid in heptane 
and not on extracts of plasma. 
In this paper, we report on the reliability of the 
proposed extraction procedure and the ®®Ni labeling 
procedure. We determined the extent of FFA binding to 
silicic acid and evaluated the efficacy of phosphate 
buffer to remove phospholipid from organic extracts of 
plasma. The effect of phosphate buffer pH on efficiency 
of extraction of FFA from plasma or bovine serum albumin 
(BSA) solutions was determined. We also determined if Ni 
formed a chloroform-heptane soluble complex with lactic, 
pyruvic, acetic and g-hydroxybutyric acids and with 
lecithin or cephalin. Finally, we observed the effects of 
Ni specific radioactivity (SRA) in the ®'Ni working 
solution on the molar ratios of FFA and Ni existing as 
FFA: Ni complex by labeling standard solutions of stearic 
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acid with ®®Ni to determine if the FFA:Ni molar ratio 
reported by Ho (14) was constant. 
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MATERIALS AND METHODS 
Solutions 
EXTRACTION SOLUTION: 32 ml of chloroform was mixed 
with 65 ml of n-heptane and 3 ml of methanol. 
PHOSPHATE BUFFER: This was prepared as described by 
Falholt et al. (11). The pH was adjusted to 6.4 
using .5N NaOH solution. 
LABELING SOLUTION: 55 ml of chloroform was mixed with 
45 ml of n-heptane. 
STOCK SOLUTIONS: (1) Saturated aqueous solution of 
sodium sulfate. (2) Saturated aqueous solution 
of potassium sulfate. (3) Nicklous nitrate 
stock solution: 0.2 mmoles of nicklous nitrate 
and 0.8 ml of glacial acetic acid were dissolved 
in the sodium sulfate stock solution to a 
volume of 100 ml. (4) ®'Ni primary solution: 
2.0 mCi of ®®Ni nitrate was diluted with 
nicklous nitrate stock solution to a volume of 
10 ml (2uCi/10ul). 
®^ Ni WORKING SOLUTION: The working solution should 
be used within 24 hours after preparation. One 
ml of nicklous nitrate stock solution, 0.85 ml 
of saturated potassium sulfate solution, 150 pi 
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of triethanolamine, and 10 ul of ®^ Ni primary 
solution were mixed. 100 ul of this solution 
contains 100 nmoles Ni^ * and 0.0995 viCi®®Ni 
(SRA=2209 DPM/nmole Ni). This solution was 
prepared according to Ho (14). 
STEARIC ACID STANDARD SOLUTIONS: A 1 mM solution of 
stearic acid in heptane was prepared, and 
aliquots of this solution were diluted with 
heptane to give standard solutions ranging from 
.06 to .75 mM stearic acid. 
Procedure 
The FFA radiochemical assay consists of three separate 
stages: I. extraction of FFA from the sample, II. 
labeling the FFA extract with Ni, III. labeling the 
stearic acid standards with Ni. The extraction tubes 
were acid-washed before use. Plasma samples and stearic 
acid standards were assayed in triplicate. 
I. Extraction of FFA from plasma or incubation media. 
To a silanized screw-top culture tube (extraction 
tube) are added 50 ul of plasma or incubation media, and 
4 ml of extraction solution. Tubes are vortexed rapidly 
for 2 minutes, allowed to stand for 10 minutes, and 
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vortexed slowly for 1 minute. If vortexed too vigorously, 
stubborn emulsions may form. Tubes are centrifuged at 
4°C at 2500 RPM for 10 minutes to give complete separation 
of the aqueous and organic phases. An aliquot [2 ml 
suggested) of the upper organic phase is transferred to 
a silanized 13 x 100 mm disposable culture tube (labeling 
tube), and is evaporated to dryness under a stream of air. 
The extraction procedure also is performed using 50 iil 
aliquots of water (water blanks). 
II. Labeling FFA from extracted sample with Ni. 
To each labeling tube containing the FFA extract are 
added 1 ml labeling solution, and 100 lil ®^ Ni working 
solution. The tube is stoppered immediately and vortexed 
rapidly for 20 seconds, taking care not to allow contents 
to contact the rubber stopper. Approximately 1 g of 
anhydrous sodium sulfate is added, the tube is stoppered, 
vortexed for approximately 5 seconds, and allowed to 
stand until the solution clears, indicating that all ®^ Ni 
working solution has been absorbed by the sodium sulfate. 
A 250 yl aliquot of the labeling solution is transferred 
to a scintillation vial, and evaporated to dryness under 
a stream of air to avoid chemical quenching. Nine ml of 
EP-Readysolv scintillation fluid are added, and vials are 
counted in a liquid scintillation counter. 
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III. Labeling stearic acid standards with Ni 
To silanized 13 x 100 mm disposable culture tubes are 
added 200 ul of stearic acid standard solutions. It was 
found that 3.0 to 200.0 nmoles FFA per assay provided a 
sufficient range for the standard curve. The standard 
solution aliquot is evaporated to dryness under a stream 
of air. Tube contents are labeled with Ni according to 
the procedure in stage II. It is essential that sample 
extracts and standards are labeled using the same ®^ Ni 
working solution. 
A linear regression of counts per minute in the 
labeling solution versus nmoles FFA per assay is obtained 
from the standard solutions. Water blank counts are sub­
tracted from sample counts and these values are factored 
according to the fraction of FFA extract dried for 
labeling, and nmoles FFA per assay are calculated from the 
standard curve. FFA per assay is factored to give FFA per 
liter of plasma (e.g., 15 nmoles FFA per assay per 50 ul 
plasma = 300 nmoles FFA/ml plasma = 0.3 mM FFA in plasma). 
Standard solutions of stearic acid are not subjected to 
the sample extraction procedure because the FFA are not 
protein bound, and the extraction procedure, in this case, 
would simply be a dilution procedure. A zero stearic acid 
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standard should not be used because subtraction of water 
blank counts from sample counts corrects for background 
radioactivity associated with the labeling procedure. 
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RESULTS AND DISCUSSION 
To determine if a linear response could be obtained 
using the proposed procedure, cow plasma, with volumes 
ranging from 10 to 600 ul per assay, was extracted and 
labeled with Ni. The relationship between volume of plasma 
per assay and amount of Ni recovered in the labeling 
solution was linear (Table A4). Plasma FFA concentrations 
calculated from these data were essentially the same re­
gardless of the volume of plasma extracted, except for 
the assays using 10 yl of plasma (Table AS). Results 
indicate that the assay, using a ®^ Ni working solution 
with a SRA of 1120 CPM per nmole Ni, was not sensitive 
enough to allow accurate determination of less than 2.5 
nmoles of FFA per assay. However, assay sensitivity can 
be increased if Ni SRA in the working solution is in­
creased (14) . 
Table A4. Amount of Ni recovered in labeling solution as 
affected by volume of plasma per assay 
Ni recovered (nmoles) Volume of plasma (yl) 
.3 10 
1.0 25 
1.7 50 
3.0 100 
6 . 6  2 0 0  
11.6 400 
16.5 600 
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Table AS. Effect of sample volume on FFA determinations 
FFA per Plasma FFA 
Plasma volume (yl) assay (nmoles) concentration (mM) 
10 .70 .060 
25 2.5 .101 
50 5.3 .106 
100 9.5 .095 
200 22.5 .113 
400 39.8 .100 
600 57.1 .095 
C^alculated from standard curve of stearic acid (0 
to 100 nmoles per assay). 
To determine if silicic acid binds FFA, solutions of 
[U-i\C] stearate conjugated to BSA (10) were extracted 
using the mixture of Dole and Meinertz (7). Two ml of the 
heptane layer was transferred to tubes containing 0, 50, 
100 or 200 mg of silicic acid and then two ml of chloroform 
were added. Tubes were vortexed, centrifuged, and an aliquot 
of the silicic acid-treated organic solution was counted. 
The recovery of ^ C^-stearate from the organic solution 
decreased as the amount of silicic acid increased (Table 
A6). 
Table A6. Amount of ^ C^-stearate recovered from labeling 
solution as affected by silicic acid 
*^*0-stearate recovered (%) Silicic acid per assay (mg) 
94 0 
87 50 
82 100 
71 200 
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The efficiency and linearity of extraction using the 
proposed extraction solution. Dole's extraction solution 
(7), and Dole's extraction solution with two levels of 
silicic acid (Ho's extraction procedure) was tested using 
•^^ C-stearate conjugated to BSA. Results are in Table A7. 
Using the proposed extraction solution, recovery of ^ *C-
stearate was linear over the range of volumes extracted 
and recovery was at least 93% of initial radioactivity. 
However, recovery of ^ C^-stearate decreased as sample 
volume increased. Dole's extraction solution produced 
lower recoveries of ^^ C-stearate than the proposed 
extraction solution. When silicic acid, at a concentration 
of 12.5 mg per ml chloroform-heptane, was used with Dole's 
extraction solution, recovery of ^ C^-stearate decreased, 
except for the 25 yl aliquot. Recovery of ^ C^-stearate 
seemed to decrease as sample volume increased. When 37.5 
mg of silicic acid per ml of chloroform-heptane was used 
following extraction with Dole's solution, recovery of 
i*C-stearate for all sample volumes decreased further. 
Ho (14) recommended using 5 mg of silicic acid per 160 ul 
of chloroform-heptane (31 mg per ml) to prevent coextrac-
tion of FFA and phospholipid from plasma. The data pre­
sented herein indicate that the proposed extraction 
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Table A7. Efficiency of extraction of "^"C-stearate from 
BSA in aqueous solution as affected by-
extraction solution and silicic acid 
Extraction 
method 25 
Volume i^ C-Stearate-BSA 
solution per assay (yl) 
50 75 100 125 150 
Proposed solution 
Dole's solution 
Dole's solution plus: 
50 mg silicic acid 
150 mg silicic acid 
percent recoveries 
102 99 97 95 97 93 
94 94 93 92 93 91 
97 88 87 85 87 82 
90 88 83 80 82 81 
solution gave complete or near complete extraction of ^ C^-
stearate from BSA solutions. Recovery of ^^ C-stearate 
using Dole's extraction solution was lower than recoveries 
using the proposed extraction solution, but recovery was 
still acceptable. However, ^ C^-stearate recovery from 
chloroform-heptane containing silicic acid was markedly 
reduced, indicating that silicic acid should not be used 
to bind phospholipid when quantitative extraction of FFA 
is necessary. 
The effects of pH of phosphate buffer on recovery of 
i^ C-stearate from BSA solution and the relative recovery 
of Ni in organic extracts of plasma are in Table A8. The 
recovery of ^^ C-stearate from the extraction solution was 
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Table A8. Efficiency of extraction as affected by pH of 
phosphate buffer 
Phosphate 
buffer pH 
Counts 
recovered (%) 
Relative recovery of , 
Ni in labeling solution 
7.0 96 91 
6.4 97 100 . 
5.7 106 96 
3.5 103 89 
2.8 105 90 
2.0 102 91 
100 ul of i*C-stearic acid-BSA complex was extracted 
with 4 ml CHM, using 3 ml phosphate buffer (initial 
counts = 3990 ± 229 CPM). 
50 Til of steer plasma was extracted with 4 ml CHM, 
using 3 ml phosphate buffer. Values are relative to pH 
6.4 phosphate buffer. 
not markedly affected by pH of the phosphate buffer but 
recovery seemed to be lower when pH 7.0 and 6.4 buffers 
were used. Error in pipetting probably accounts for 
recoveries greater than 100%. Itaya and Ui (18) reported 
maximal extraction of FFA from BSA solution when the pH 
of the phosphate buffer was between 6 and 7. The amount 
of Ni recovered in organic extracts of plasma is an 
indication of the amount of FFA extracted from a sample. 
Ni recovery was maximum when pH 6.4 phosphate buffer was 
used (Table AS). At lower and higher pH, Ni recovery 
was slightly reduced, indicating lower FFA extraction 
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from plasma. Itaya and Ui (18) reported similar but more 
marked reductions in efficiency of FFA extraction from 
plasma when phosphate buffer pH was lower or greater than 
6 . 2 .  
To determine if FFA was quantitatively recovered 
following extraction of the sample, pipetting the organic 
extract, and drying the labeling solution, plasma plus 
known amounts of stearic acid was extracted and labeled. 
Values for recovery of added stearic acid from the extrac­
tion solution are in Table A9. Results indicate that 
recovery of stearic acid following the extraction and 
labeling procedures was quantitative. 
To determine if lactic, pyruvic, 6-hydroxybutyric or 
acetic acids and if lecithin or cephalin formed a chloro­
form-heptane soluble complex with Ni, 100 yl of ®^ Ni 
working solution were added to standard solutions of each 
compound. After vortexing, sodium sulfate was added to 
tubes to remove the aqueous Ni phase. Aliquots of 
labeling solution were counted. Results are in Table AlO. 
Using water as a zero or background reference, physio­
logical or excess amounts of $-hydroxybutyric, acetic and 
pyruvic acids did not form a chloroform-heptane soluble 
complex with Ni. Physiological amounts of lactic acid 
did not bind Ni, but excess lactic acid bound slightly 
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Table A9. Recovery of stearic acid additions from steer 
plasma* 
FFA Stearic acid 
per assay recovered Recovery of added 
Assay contents (nmoles) (nmoles) stearic acid (%) 
50 lil plasma 15.6 
50 ]il plasma plus; 
49.6 nmoles 
stearic acid 67.9 52.3 105.4 
99.2 nmoles 
stearic acid 115.6 100 100.8 
198.4 nmoles 
stearic acid 218.9 203.3 102.5 
Stearic acid in heptane was added to extraction 
tubes, evaporated, SO iil of plasma from a phlorizin-
treated steer was added, and the contents were extracted 
and labeled. 
greater amounts of Ni. Levels of lactic acid this high 
are not likely to be encountered, even following strenuous 
exercise in humans or during periods of lactic acidosis in 
ruminants. Lecithin did not bind significant amounts of 
Ni when present in subnormal, physiological, or excess 
amounts. Chlouverakis and Hojnicki (3) reported that 
lecithin did not form a chloroform-heptane soluble complex 
with **Co. Cephalin, at all levels tested, formed a 
chloroform-heptane soluble complex with Ni. 
Table AlO. Formation of chloroform-heptane soluble complexes with ®'Ni by 
stearic acid and other metabolites 
Equivalent concentration Ni recovered in 
Assay contents* in plasma^  (mM) labeling solution (nmoles) 
Stearic acid (100 nmoles) 2.0 23.4 
Water .8 
BHBA: 20 nmoles .4 .8 
300 nmoles 6.0 .8 
Aciitate: 30 nmoles .6 .6 
150 nmoles 3.0 .8 
Pyruvate: 10 nmoles .2 .7 
200 nmoles 4.0 .7 
Lactate: 100 nmoles 2.0 .8 
2000 nmoles 40.0 2.0 
Lecithin: 25 nmoles .5 .8 
SO nmoles 1.0 1.3 
100 nmoles 2.0 1.3 
200 nmoles 4.0 .8 
Cephalin: 25 nmoles .5 8.9 
50 nmoles 1.0 12.5 
100 nmoles 2.0 13.9 
200 nmoles 4.0 13.5 
*Assay contents were not extracted or washed with phosphate buffer prior to 
labeling. 
I^f 50 yl of plasma is used per assay, amounts per assay range from normal 
physiological levels to levels far in excess of physiological. 
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Total plasma phospholipid concentrations average 2.2 
mM in humans (29), 1.25 mM in cows (2), and 0.7 mM in 
sheep (13). In ruminants and non-ruminants, 80% of the 
total lipid phosphorus in plasma is in lecithin (plus 
lysolecithin). Cephalin accounts for 2% of the total 
lipid phosphorous in non-ruminants, 2.4% in sheep, and is 
not detectable in plasma of cows (5). Amounts of cephalin 
used in this experiment greatly exceeded physiological 
amounts in plasma. The results of the Ni binding expri­
ment indicate that lactic, 3-hydroxybutyric, acetic, and 
pyruvic acids do not interfere with the assay. We 
observed that, following addition of 100 yl of ®^ Ni work­
ing solution, lecithin and cephalin solutions remained 
cloudy long after addition of sodium sulfate, indicating 
that the solubility of the aqueous ®^ Ni working solution 
in the labeling solution was enhanced by these phospho­
lipids. If the labeling solution is not allowed enough 
time to clear following addition of sodium sulfate, 
erroneously high ®^ Ni counts will be obtained due to 
solubilized Ni, rather than phospholipid-bound Ni, in the 
labeling solution. It was observed that the aqueous ®®Ni 
working solution could not be separated from labeling 
solution containing lecithin or cephalin by centrifugation. 
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The effects of lactic, B-hydroxybutyric, acetic, and 
pyruvic acids and lecithin on the amount of Ni recovered 
in the labeling solution in the presence of stearic acid 
following dilution with the extraction solution and 
washing with phosphate buffer are in Table All. The 
effect of cephalin on Ni recovery was not examined be­
cause it usually is absent, or is very low in concentra­
tion in plasma. Using the amount of Ni bound by 100 
nmoles of stearic acid as a reference, results indicate 
that, with one exception, the amount of Ni recovered in 
the organic phase did not increase by more than 3.9% 
in response to the addition of these plasma metabolites. 
When 200 nmoles lecithin was added to each assay. Ni 
recovery was 12% greater than when no lecithin was added. 
However, this quantity of lecithin is greater than 
quantities found in 50 yl of plasma. 
To determine if lecithin affected recovery of Ni in 
organic extracts of plasma, lecithin was added to plasma, 
extracted, washed with phosphate buffer, and labeled 
with ®®Ni. Results are in Table A12. Using the amount 
of Ni recovered in the labeling solution of plasma ex­
tracts as a reference, 25 nmoles of lecithin per assay 
unexplainably caused a decrease in Ni recovery, but 50, 
Table All. Effect of metabolites on the amount of Ni recovered in the labeling 
solution in the presence of stearic acid 
Assay contents* 
Ni recovered in labeling 
solution (nmoles) 
Stearic acid (100 nmoles) 23.5 
Stearic acid (100 nmoles) plus: 
Lactate - 100 nmoles 23.4 
2000 nmoles 24.3 
BHBA - 20 nmoles 23.7 
300 nmoles 23.2 
Acetate - 30 nmoles 23.1 
150 nmoles 23.1 
Pyruvate - 10 nmoles 23.3 
200 nmoles 23.6 
Lecithin - 25 nmoles 23.2 
50 nmoles 2 4 . 4  
100 nmoles 23.5 
200 nmoles 26.2 
Water .8 
Chloroform . 8  
S^amples were extracted with 4 ml of extraction solution and then washed 
with 3 ml of phosphate buffer. 
Table A12. Effect of lecithin on amount of Ni recovered in labeled solutions 
of steer plasma extracts 
Assay contents® 
Ni recovered in labeling 
solution (nmoles) 
Calculated 
of FFA in 
concent 
plasma' 
;ration 
> (mM) 
Plasma (50 yl) 5.4 .32 
Plasma (50 yl) plus: 
Lecithin - 25 nmoles 5.0 .29 
50 nmoles 5.9 .36 
100 nmoles 5.6 .33 
200 nmoles 5.7 .35 
Water .8 
S^amples were extracted with 4 ml of extraction solution and then washed 
with 3 ml of phosphate buffer. 
V^alues calculated by using net DPM in labeling solution. 
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100, and 200 nmoles of lecithin caused an increase in Ni 
recovery. Because lecithin did not form a complex with Ni 
(Table AlO), it seems that the observed increase in Ni re­
covery is the result of a phospholipid-induced increase 
in the solubility of aqueous ®'Ni working solution in the 
labeling solution, rather than the result of the formation 
of a chloroform-heptane soluble lecithin-Ni complex. 
Using radioactivity in the labeling solution and a 
standard curve to calculate plasma FFA concentrations, 
addition of 25 nmoles lecithin to plasma caused a 9.4% 
decrease in calculated FFA concentrations, but 50, 100, 
and 200 nmoles of lecithin caused a 12.5, 3.1, and 9.4% 
increase in values. Differences in calculated FFA concen­
trations seem to be random and may be partly accounted 
for by error associated with the assay. Furthermore, 
because the plasma aliquot already contained naturally 
occurring lecithin, any lecithin addition increased con­
centrations of phospholipid above normal physiological 
levels. As occurred with the lecithin and cephalin assays 
reported in Table AlO, it was observed that additional 
phospholipid in plasma extracts caused the labeling 
solution to remain cloudy long after addition of sodium 
sulfate. This apparent phospholipid-induced increase in 
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solubility of aqueous ®^ Ni working solution in the label­
ing solution may have caused Ho (14) to conclude that 
phospholipids formed a chloroform-heptane soluble complex 
with Ni. 
Ho [14) using 100 nmoles nicklous nitrate and .0995 
liCi®®Ni CSRA = 2200 DPM/nmole Ni) to label 1 to 40 
nmoles stearic acid, reported the FFA:Ni molar ratio in 
the labeling solution, following centrifugation to remove 
the aqueous Ni working solution, was 2.04, indicating that 
one mole of Ni bound approximately two moles of FFA. 
DeBrabander and Verbeke (6) using 1000 nmoles nicklous 
nitrate and .0995 uCi®^ Ni (SRA = 220 DPM/nmole Ni) to 
label 40 to 400 nmoles stearic acid reported the FFA:Ni 
molar ratio in the labeling solution following centri­
fugation was 2.47 and the ratio following absorption of 
aqueous ®'Ni working solution by sodium sulfate was 1.92. 
Ho (14) reported that because the FFA:Ni molar ratio in 
the labeling solution consistently approached 2.0, the 
FFA content of a sample could be calculated directly from 
the amount of Ni recovered in the labeling solution. The 
amount of Ni in the labeling solution existing as a FFA-
Ni complex is easily calculated if the SRA of the ®®Ni 
working solution is known. The effects of different Ni 
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specific radioactivities in the ®'Ni working solution on 
the FFA:Ni molar ratio in the labeling solution, following 
absorption of the aqueous phase by sodium sulfate were 
investigated to determine if the amount of Ni recovered 
in the labeling solution was an accurate indicator of 
the amount of FFA per assay. Zero, 6, 12, 25, 60, 99, 
and 198 nmoles of stearic acid were labeled with Ni using 
®^ Ni working solutions of varying SRA. Results are in 
Table A13. The SRA of the ®^ Ni working solution markedly 
affected the FFA:Ni molar ratios in the labeling solution. 
As Ni SRA increased, the FFA:Ni molar ratio increased. 
Theoretically, a given quantity of FFA should bind a 
constant amount of Ni. But, as reported herein, when Ni 
SRA increased, the amount of Ni bound by each amount of 
stearic acid decreased. The rate of increase in Ni SRA 
was greater than the rate of decrease in the amount of Ni 
bound by a given quantity of FFA, resulting in a dis­
proportionate shift in the amount of radioactive and non­
radioactive Ni bound by FFA. In the present study, as 
opposed to the study of Ho (14), the FFA:Ni molar ration 
in the labeling solution approached 2.0 only when Ni SRA 
was 215 DPM/nmole. However, our observations are in 
agreement with the observations of DeBrabander and 
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Verbeke (6). These results indicate that calculation of 
FFA quantity directly from the amount of Ni recovered in 
the labeling solution could lead to serious errors and 
that a standard curve should be used for FFA determina­
tions. 
Table A13. Molar ratio of FFA to Ni in labeling solution 
as affected by specific radioactivity of 
®®Ni working solution 
FFA per assay 
Çnmoles) 
Specific radioactivity of **Ni [DPM/nmole] 
81 215 443 949 2176 4397 
0 8.5 4.5 2.5 1.3 .7 .3 
6.2 12.1 6.7 4.7 2.7 1.8 1.0 
12.4 18.7 11.7 7.7 4.9 3.2 1.9 
24.8 22.9 17.1 12.6 10.0 6.5 3.7 
49.6 37.0 28.9 22.3 17.4 12.7 8.6 
99.2 66.8 52.7 45.1 35.3 27.7 18.8 
198.4 128.8 107.5 88.2 74.2 54.0 32.3 
FFA:Ni ratio 1.66 1.94 2.31 2.72 3.68 6 . 0 2  
In vivo studies of intermediary metabolism frequently 
require intravenous injections of isotopically labeled 
compounds. In our laboratory, for instance, and 
[6-®H]glucose is given intravenously to cattle to measure 
kinetics of glucose metabolism. Since the proposed FFA 
procedure is a radiochemical assay, we wanted to determine 
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if any radioactivity originating from and H^-labeled 
glucose in plasma was retained by the organic phase follow­
ing the extraction procedure. The radioactivity in a 
plasma sample taken from a steer which had received an 
intravenous injection of and glucose was 117 DPM 
per SO yl. Equal volumes of plasma were extracted, 
according to the proposed procedure, and the radioactivity 
in the organic phase following a phosphate buffer wash 
was 33 DPM. Background radiation was 30 DPM. These 
results indicate that 100% of the radioactivity originating 
from and labeled compounds in plasma was retained 
by the aqueous phase of the extraction mixture and did not 
contaminate the organic phase. 
Within-run precision of the assay was determined 
using plasma from phlorizin-treated steers and a non-
lactating cow. Results are in Table A14. Because the 
coefficient of variation was less than 10% (average C.V. 
= 6.5%) precision was acceptable, indicating that the 
assay was reliable. 
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Table A14. Within-run precision of the ®^ Ni radiochemical 
assay 
Mean FFA 
Number of concentration 
observations in plasma CmM) SD SEM CV 
7 .293 .026 .010 8 .87 
10 .326 .020 .006 6 .13 
5 .129 .014 .006 4 .65 
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